id	sid	tid	token	lemma	pos
hls-10800	1	1	hrev_master	hrev_master	NOUN
hls-10800	2	1	[	[	X
hls-10800	2	2	healthcare	healthcare	NOUN
hls-10800	2	3	in	in	ADP
hls-10800	2	4	low	low	ADJ
hls-10800	2	5	-	-	PUNCT
hls-10800	2	6	resource	resource	NOUN
hls-10800	2	7	settings	setting	NOUN
hls-10800	2	8	2022	2022	NUM
hls-10800	2	9	;	;	PUNCT
hls-10800	2	10	10:10800	10:10800	NUM
hls-10800	2	11	]	]	X
hls-10800	3	1	[	[	X
hls-10800	3	2	page	page	NOUN
hls-10800	3	3	61	61	NUM
hls-10800	3	4	]	]	PUNCT
hls-10800	3	5	covid-19	covid-19	PROPN
hls-10800	3	6	and	and	CCONJ
hls-10800	3	7	neurological	neurological	ADJ
hls-10800	3	8	complications	complication	NOUN
hls-10800	3	9	:	:	PUNCT
hls-10800	3	10	a	a	DET
hls-10800	3	11	review	review	NOUN
hls-10800	3	12	feryal	feryal	ADJ
hls-10800	3	13	dabagh	dabagh	NOUN
hls-10800	3	14	-	-	PUNCT
hls-10800	3	15	gorjani,1	gorjani,1	NOUN
hls-10800	3	16	mohammad	mohammad	PROPN
hls-10800	3	17	-	-	PUNCT
hls-10800	3	18	ali	ali	PROPN
hls-10800	3	19	fatehchehr2	fatehchehr2	PROPN
hls-10800	3	20	1department	1department	NUM
hls-10800	3	21	of	of	ADP
hls-10800	3	22	immunology	immunology	NOUN
hls-10800	3	23	,	,	PUNCT
hls-10800	3	24	school	school	NOUN
hls-10800	3	25	of	of	ADP
hls-10800	3	26	medicine	medicine	NOUN
hls-10800	3	27	,	,	PUNCT
hls-10800	3	28	shiraz	shiraz	PROPN
hls-10800	3	29	university	university	PROPN
hls-10800	3	30	of	of	ADP
hls-10800	3	31	medical	medical	ADJ
hls-10800	3	32	sciences	sciences	PROPN
hls-10800	3	33	,	,	PUNCT
hls-10800	3	34	shiraz	shiraz	PROPN
hls-10800	3	35	;	;	PUNCT
hls-10800	3	36	2department	2department	NUM
hls-10800	3	37	of	of	ADP
hls-10800	3	38	computer	computer	NOUN
hls-10800	3	39	engineering	engineering	NOUN
hls-10800	3	40	,	,	PUNCT
hls-10800	3	41	amirkabir	amirkabir	NOUN
hls-10800	3	42	university	university	PROPN
hls-10800	3	43	of	of	ADP
hls-10800	3	44	technology	technology	PROPN
hls-10800	3	45	,	,	PUNCT
hls-10800	3	46	tehran	tehran	PROPN
hls-10800	3	47	,	,	PUNCT
hls-10800	3	48	iran	iran	PROPN
hls-10800	3	49	abstract	abstract	ADJ
hls-10800	3	50	infections	infection	NOUN
hls-10800	3	51	with	with	ADP
hls-10800	3	52	viruses	virus	NOUN
hls-10800	3	53	have	have	VERB
hls-10800	3	54	detrimental	detrimental	ADJ
hls-10800	3	55	effects	effect	NOUN
hls-10800	3	56	on	on	ADP
hls-10800	3	57	neurological	neurological	ADJ
hls-10800	3	58	functions	function	NOUN
hls-10800	3	59	,	,	PUNCT
hls-10800	3	60	and	and	CCONJ
hls-10800	3	61	even	even	ADV
hls-10800	3	62	cause	cause	VERB
hls-10800	3	63	severe	severe	ADJ
hls-10800	3	64	neurological	neurological	ADJ
hls-10800	3	65	damage	damage	NOUN
hls-10800	3	66	.	.	PUNCT
hls-10800	4	1	there	there	PRON
hls-10800	4	2	is	be	VERB
hls-10800	4	3	mounting	mount	VERB
hls-10800	4	4	evidence	evidence	NOUN
hls-10800	4	5	that	that	SCONJ
hls-10800	4	6	coronaviruses	coronaviruse	NOUN
hls-10800	4	7	(	(	PUNCT
hls-10800	4	8	cov	cov	NOUN
hls-10800	4	9	)	)	PUNCT
hls-10800	4	10	as	as	ADV
hls-10800	4	11	well	well	ADV
hls-10800	4	12	as	as	ADP
hls-10800	4	13	sars	sar	NOUN
hls-10800	4	14	-	-	PUNCT
hls-10800	4	15	cov-2	cov-2	NOUN
hls-10800	4	16	exhibit	exhibit	NOUN
hls-10800	4	17	neurotropic	neurotropic	ADJ
hls-10800	4	18	abilities	ability	NOUN
hls-10800	4	19	and	and	CCONJ
hls-10800	4	20	might	might	AUX
hls-10800	4	21	cause	cause	VERB
hls-10800	4	22	neurological	neurological	ADJ
hls-10800	4	23	problems	problem	NOUN
hls-10800	4	24	.	.	PUNCT
hls-10800	5	1	neuroinvasive	neuroinvasive	ADJ
hls-10800	5	2	viruses	virus	NOUN
hls-10800	5	3	are	be	AUX
hls-10800	5	4	not	not	PART
hls-10800	5	5	fully	fully	ADV
hls-10800	5	6	understood	understand	VERB
hls-10800	5	7	,	,	PUNCT
hls-10800	5	8	which	which	PRON
hls-10800	5	9	makes	make	VERB
hls-10800	5	10	it	it	PRON
hls-10800	5	11	important	important	ADJ
hls-10800	5	12	to	to	PART
hls-10800	5	13	investigate	investigate	VERB
hls-10800	5	14	their	their	PRON
hls-10800	5	15	impact	impact	NOUN
hls-10800	5	16	on	on	ADP
hls-10800	5	17	the	the	DET
hls-10800	5	18	nervous	nervous	ADJ
hls-10800	5	19	system	system	NOUN
hls-10800	5	20	.	.	PUNCT
hls-10800	6	1	in	in	ADP
hls-10800	6	2	this	this	DET
hls-10800	6	3	paper	paper	NOUN
hls-10800	6	4	,	,	PUNCT
hls-10800	6	5	we	we	PRON
hls-10800	6	6	review	review	VERB
hls-10800	6	7	research	research	NOUN
hls-10800	6	8	into	into	ADP
hls-10800	6	9	neurological	neurological	ADJ
hls-10800	6	10	complications	complication	NOUN
hls-10800	6	11	associated	associate	VERB
hls-10800	6	12	with	with	ADP
hls-10800	6	13	cov	cov	PROPN
hls-10800	6	14	.	.	PUNCT
hls-10800	7	1	introduction	introduction	NOUN
hls-10800	7	2	on	on	ADP
hls-10800	7	3	march	march	PROPN
hls-10800	7	4	11th	11th	NOUN
hls-10800	7	5	,	,	PUNCT
hls-10800	7	6	2020	2020	NUM
hls-10800	7	7	,	,	PUNCT
hls-10800	7	8	coronavirus	coronavirus	NOUN
hls-10800	7	9	disease	disease	NOUN
hls-10800	7	10	2019	2019	NUM
hls-10800	7	11	(	(	PUNCT
hls-10800	7	12	covid-19	covid-19	PROPN
hls-10800	7	13	)	)	PUNCT
hls-10800	7	14	was	be	AUX
hls-10800	7	15	affirmed	affirm	VERB
hls-10800	7	16	by	by	ADP
hls-10800	7	17	the	the	DET
hls-10800	7	18	world	world	PROPN
hls-10800	7	19	health	health	PROPN
hls-10800	7	20	organization	organization	NOUN
hls-10800	7	21	as	as	ADP
hls-10800	7	22	a	a	DET
hls-10800	7	23	pandemic	pandemic	NOUN
hls-10800	7	24	.	.	PUNCT
hls-10800	8	1	it	it	PRON
hls-10800	8	2	was	be	AUX
hls-10800	8	3	reported	report	VERB
hls-10800	8	4	at	at	ADP
hls-10800	8	5	the	the	DET
hls-10800	8	6	time	time	NOUN
hls-10800	8	7	as	as	ADP
hls-10800	8	8	an	an	DET
hls-10800	8	9	epidemic	epidemic	NOUN
hls-10800	8	10	disease	disease	NOUN
hls-10800	8	11	in	in	ADP
hls-10800	8	12	wuhan	wuhan	PROPN
hls-10800	8	13	,	,	PUNCT
hls-10800	8	14	hubei	hubei	PROPN
hls-10800	8	15	province	province	PROPN
hls-10800	8	16	,	,	PUNCT
hls-10800	8	17	china	china	PROPN
hls-10800	8	18	in	in	ADP
hls-10800	8	19	december	december	PROPN
hls-10800	8	20	2019	2019	NUM
hls-10800	8	21	.	.	PUNCT
hls-10800	9	1	the	the	DET
hls-10800	9	2	cause	cause	NOUN
hls-10800	9	3	of	of	ADP
hls-10800	9	4	the	the	DET
hls-10800	9	5	severe	severe	ADJ
hls-10800	9	6	acute	acute	ADJ
hls-10800	9	7	respiratory	respiratory	ADJ
hls-10800	9	8	syndrome	syndrome	NOUN
hls-10800	9	9	that	that	PRON
hls-10800	9	10	became	became	AUX
hls-10800	9	11	known	know	VERB
hls-10800	9	12	as	as	ADP
hls-10800	9	13	covid-19	covid-19	PROPN
hls-10800	9	14	was	be	AUX
hls-10800	9	15	a	a	DET
hls-10800	9	16	novel	novel	ADJ
hls-10800	9	17	coronavirus	coronavirus	NOUN
hls-10800	9	18	,	,	PUNCT
hls-10800	9	19	sars	sar	NOUN
hls-10800	9	20	-	-	PUNCT
hls-10800	9	21	cov-2.1	cov-2.1	VERB
hls-10800	9	22	there	there	PRON
hls-10800	9	23	are	be	VERB
hls-10800	9	24	seven	seven	NUM
hls-10800	9	25	members	member	NOUN
hls-10800	9	26	in	in	ADP
hls-10800	9	27	the	the	DET
hls-10800	9	28	cov	cov	PROPN
hls-10800	9	29	family	family	NOUN
hls-10800	9	30	and	and	CCONJ
hls-10800	9	31	sars	sar	NOUN
hls-10800	9	32	-	-	PUNCT
hls-10800	9	33	cov-2	cov-2	NUM
hls-10800	9	34	is	be	AUX
hls-10800	9	35	one	one	NUM
hls-10800	9	36	of	of	ADP
hls-10800	9	37	them	they	PRON
hls-10800	9	38	which	which	PRON
hls-10800	9	39	can	can	AUX
hls-10800	9	40	infect	infect	VERB
hls-10800	9	41	humans,2	humans,2	NOUN
hls-10800	9	42	and	and	CCONJ
hls-10800	9	43	it	it	PRON
hls-10800	9	44	belongs	belong	VERB
hls-10800	9	45	to	to	ADP
hls-10800	9	46	the	the	DET
hls-10800	9	47	equal	equal	ADJ
hls-10800	9	48	lineage	lineage	NOUN
hls-10800	9	49	of	of	ADP
hls-10800	9	50	covs	covs	NOUN
hls-10800	9	51	,	,	PUNCT
hls-10800	9	52	which	which	PRON
hls-10800	9	53	reasons	reason	VERB
hls-10800	9	54	sars	sar	NOUN
hls-10800	9	55	;	;	PUNCT
hls-10800	9	56	however	however	ADV
hls-10800	9	57	,	,	PUNCT
hls-10800	9	58	this	this	DET
hls-10800	9	59	novel	novel	ADJ
hls-10800	9	60	virus	virus	NOUN
hls-10800	9	61	is	be	AUX
hls-10800	9	62	genetically	genetically	ADV
hls-10800	9	63	distinct	distinct	ADJ
hls-10800	9	64	.	.	PUNCT
hls-10800	10	1	the	the	DET
hls-10800	10	2	emergence	emergence	NOUN
hls-10800	10	3	of	of	ADP
hls-10800	10	4	covid-19	covid-19	PROPN
hls-10800	10	5	is	be	AUX
hls-10800	10	6	a	a	DET
hls-10800	10	7	serious	serious	ADJ
hls-10800	10	8	threat	threat	NOUN
hls-10800	10	9	to	to	ADP
hls-10800	10	10	global	global	ADJ
hls-10800	10	11	public	public	ADJ
hls-10800	10	12	health.3	health.3	NOUN
hls-10800	10	13	evidence	evidence	NOUN
hls-10800	10	14	shows	show	VERB
hls-10800	10	15	these	these	DET
hls-10800	10	16	viruses	virus	NOUN
hls-10800	10	17	can	can	AUX
hls-10800	10	18	affect	affect	VERB
hls-10800	10	19	different	different	ADJ
hls-10800	10	20	human	human	ADJ
hls-10800	10	21	systems	system	NOUN
hls-10800	10	22	such	such	ADJ
hls-10800	10	23	as	as	ADP
hls-10800	10	24	the	the	DET
hls-10800	10	25	respiratory	respiratory	ADJ
hls-10800	10	26	,	,	PUNCT
hls-10800	10	27	nervous	nervous	ADJ
hls-10800	10	28	,	,	PUNCT
hls-10800	10	29	hepatic	hepatic	ADJ
hls-10800	10	30	,	,	PUNCT
hls-10800	10	31	and	and	CCONJ
hls-10800	10	32	gastrointestinal	gastrointestinal	ADJ
hls-10800	10	33	systems.4	systems.4	PROPN
hls-10800	10	34	neurological	neurological	ADJ
hls-10800	10	35	manifestations	manifestation	NOUN
hls-10800	10	36	are	be	AUX
hls-10800	10	37	the	the	DET
hls-10800	10	38	second	second	ADJ
hls-10800	10	39	most	most	ADV
hls-10800	10	40	common	common	ADJ
hls-10800	10	41	symptom	symptom	NOUN
hls-10800	10	42	after	after	ADP
hls-10800	10	43	respiratory	respiratory	ADJ
hls-10800	10	44	symptoms5	symptoms5	NOUN
hls-10800	10	45	and	and	CCONJ
hls-10800	10	46	it	it	PRON
hls-10800	10	47	can	can	AUX
hls-10800	10	48	be	be	AUX
hls-10800	10	49	seen	see	VERB
hls-10800	10	50	in	in	ADP
hls-10800	10	51	both	both	CCONJ
hls-10800	10	52	severe	severe	ADJ
hls-10800	10	53	form	form	NOUN
hls-10800	10	54	and	and	CCONJ
hls-10800	10	55	early	early	ADJ
hls-10800	10	56	stage	stage	NOUN
hls-10800	10	57	of	of	ADP
hls-10800	10	58	disease.6	disease.6	NOUN
hls-10800	10	59	headache	headache	NOUN
hls-10800	10	60	,	,	PUNCT
hls-10800	10	61	confusion	confusion	NOUN
hls-10800	10	62	,	,	PUNCT
hls-10800	10	63	dizziness	dizziness	NOUN
hls-10800	10	64	,	,	PUNCT
hls-10800	10	65	mild	mild	ADJ
hls-10800	10	66	cognitive	cognitive	ADJ
hls-10800	10	67	impairment	impairment	NOUN
hls-10800	10	68	,	,	PUNCT
hls-10800	10	69	altered	alter	VERB
hls-10800	10	70	taste	taste	NOUN
hls-10800	10	71	,	,	PUNCT
hls-10800	10	72	loss	loss	NOUN
hls-10800	10	73	of	of	ADP
hls-10800	10	74	smell	smell	NOUN
hls-10800	10	75	,	,	PUNCT
hls-10800	10	76	blurred	blurred	ADJ
hls-10800	10	77	vision	vision	NOUN
hls-10800	10	78	,	,	PUNCT
hls-10800	10	79	as	as	ADV
hls-10800	10	80	well	well	ADV
hls-10800	10	81	as	as	ADP
hls-10800	10	82	muscle	muscle	NOUN
hls-10800	10	83	and	and	CCONJ
hls-10800	10	84	nerve	nerve	NOUN
hls-10800	10	85	pain	pain	NOUN
hls-10800	10	86	are	be	AUX
hls-10800	10	87	the	the	DET
hls-10800	10	88	most	most	ADV
hls-10800	10	89	common	common	ADJ
hls-10800	10	90	manifestations	manifestation	NOUN
hls-10800	10	91	in	in	ADP
hls-10800	10	92	covid-19	covid-19	PROPN
hls-10800	10	93	patients.7	patients.7	PROPN
hls-10800	10	94	covid-19	covid-19	PROPN
hls-10800	10	95	can	can	AUX
hls-10800	10	96	develop	develop	VERB
hls-10800	10	97	neurological	neurological	ADJ
hls-10800	10	98	complications	complication	NOUN
hls-10800	10	99	either	either	CCONJ
hls-10800	10	100	by	by	ADP
hls-10800	10	101	direct	direct	ADJ
hls-10800	10	102	effect	effect	NOUN
hls-10800	10	103	on	on	ADP
hls-10800	10	104	the	the	DET
hls-10800	10	105	nervous	nervous	ADJ
hls-10800	10	106	system	system	NOUN
hls-10800	10	107	during	during	ADP
hls-10800	10	108	the	the	DET
hls-10800	10	109	acute	acute	ADJ
hls-10800	10	110	phase	phase	NOUN
hls-10800	10	111	or	or	CCONJ
hls-10800	10	112	indirectly	indirectly	ADV
hls-10800	10	113	by	by	ADP
hls-10800	10	114	immune	immune	NOUN
hls-10800	10	115	-	-	PUNCT
hls-10800	10	116	mediated	mediate	VERB
hls-10800	10	117	infection	infection	NOUN
hls-10800	10	118	,	,	PUNCT
hls-10800	10	119	which	which	PRON
hls-10800	10	120	may	may	AUX
hls-10800	10	121	appear	appear	VERB
hls-10800	10	122	even	even	ADV
hls-10800	10	123	after	after	ADP
hls-10800	10	124	months	month	NOUN
hls-10800	10	125	following	follow	VERB
hls-10800	10	126	the	the	DET
hls-10800	10	127	acute	acute	NOUN
hls-10800	10	128	phase.8,9	phase.8,9	NOUN
hls-10800	10	129	in	in	ADP
hls-10800	10	130	this	this	DET
hls-10800	10	131	review	review	NOUN
hls-10800	10	132	,	,	PUNCT
hls-10800	10	133	we	we	PRON
hls-10800	10	134	summarized	summarize	VERB
hls-10800	10	135	the	the	DET
hls-10800	10	136	studies	study	NOUN
hls-10800	10	137	that	that	PRON
hls-10800	10	138	have	have	AUX
hls-10800	10	139	shown	show	VERB
hls-10800	10	140	neurological	neurological	ADJ
hls-10800	10	141	manifestations	manifestation	NOUN
hls-10800	10	142	of	of	ADP
hls-10800	10	143	covid-19	covid-19	PROPN
hls-10800	10	144	in	in	ADP
hls-10800	10	145	patients	patient	NOUN
hls-10800	10	146	.	.	PUNCT
hls-10800	11	1	pathophysiology	pathophysiology	NOUN
hls-10800	11	2	sars	sar	NOUN
hls-10800	11	3	-	-	PUNCT
hls-10800	11	4	cov-2	cov-2	PART
hls-10800	11	5	has	have	VERB
hls-10800	11	6	a	a	DET
hls-10800	11	7	large	large	ADJ
hls-10800	11	8	envelope	envelope	NOUN
hls-10800	11	9	with	with	ADP
hls-10800	11	10	spiked	spiked	ADJ
hls-10800	11	11	proteins	protein	NOUN
hls-10800	11	12	on	on	ADP
hls-10800	11	13	its	its	PRON
hls-10800	11	14	surface	surface	NOUN
hls-10800	11	15	.	.	PUNCT
hls-10800	12	1	through	through	ADP
hls-10800	12	2	these	these	DET
hls-10800	12	3	surface	surface	NOUN
hls-10800	12	4	proteins	protein	NOUN
hls-10800	12	5	,	,	PUNCT
hls-10800	12	6	sars	sar	NOUN
hls-10800	12	7	-	-	PUNCT
hls-10800	12	8	cov-2	cov-2	PART
hls-10800	12	9	binds	bind	VERB
hls-10800	12	10	to	to	ADP
hls-10800	12	11	the	the	DET
hls-10800	12	12	human	human	ADJ
hls-10800	12	13	angiotensin	angiotensin	NOUN
hls-10800	12	14	-	-	PUNCT
hls-10800	12	15	converting	convert	VERB
hls-10800	12	16	-	-	PUNCT
hls-10800	12	17	enzyme	enzyme	NOUN
hls-10800	12	18	receptor	receptor	NOUN
hls-10800	12	19	2	2	NUM
hls-10800	12	20	(	(	PUNCT
hls-10800	12	21	ace2	ace2	PROPN
hls-10800	12	22	)	)	PUNCT
hls-10800	12	23	on	on	ADP
hls-10800	12	24	human	human	ADJ
hls-10800	12	25	cells	cell	NOUN
hls-10800	12	26	.	.	PUNCT
hls-10800	13	1	therefore	therefore	ADV
hls-10800	13	2	,	,	PUNCT
hls-10800	13	3	the	the	DET
hls-10800	13	4	presence	presence	NOUN
hls-10800	13	5	of	of	ADP
hls-10800	13	6	ace2	ace2	PROPN
hls-10800	13	7	in	in	ADP
hls-10800	13	8	humans	human	NOUN
hls-10800	13	9	plays	play	VERB
hls-10800	13	10	a	a	DET
hls-10800	13	11	key	key	ADJ
hls-10800	13	12	role	role	NOUN
hls-10800	13	13	in	in	ADP
hls-10800	13	14	the	the	DET
hls-10800	13	15	entrancing	entrancing	NOUN
hls-10800	13	16	of	of	ADP
hls-10800	13	17	virus	virus	NOUN
hls-10800	13	18	.	.	PUNCT
hls-10800	14	1	ace2	ace2	PROPN
hls-10800	14	2	is	be	AUX
hls-10800	14	3	expressed	express	VERB
hls-10800	14	4	in	in	ADP
hls-10800	14	5	many	many	ADJ
hls-10800	14	6	tissues	tissue	NOUN
hls-10800	14	7	like	like	ADP
hls-10800	14	8	the	the	DET
hls-10800	14	9	lung	lung	NOUN
hls-10800	14	10	,	,	PUNCT
hls-10800	14	11	kidney	kidney	NOUN
hls-10800	14	12	,	,	PUNCT
hls-10800	14	13	pancreas	pancrea	NOUN
hls-10800	14	14	,	,	PUNCT
hls-10800	14	15	small	small	ADJ
hls-10800	14	16	intestine	intestine	NOUN
hls-10800	14	17	,	,	PUNCT
hls-10800	14	18	testicles	testicle	NOUN
hls-10800	14	19	and	and	CCONJ
hls-10800	14	20	vascular	vascular	ADJ
hls-10800	14	21	epithelial	epithelial	ADJ
hls-10800	14	22	,	,	PUNCT
hls-10800	14	23	cns	cns	NOUN
hls-10800	14	24	,	,	PUNCT
hls-10800	14	25	including	include	VERB
hls-10800	14	26	neurons	neuron	NOUN
hls-10800	14	27	and	and	CCONJ
hls-10800	14	28	glial	glial	ADJ
hls-10800	14	29	cells.10	cells.10	NOUN
hls-10800	14	30	after	after	ADP
hls-10800	14	31	binding	bind	VERB
hls-10800	14	32	to	to	ADP
hls-10800	14	33	ace2	ace2	PROPN
hls-10800	14	34	,	,	PUNCT
hls-10800	14	35	the	the	DET
hls-10800	14	36	enzyme	enzyme	NOUN
hls-10800	14	37	tmprss2	tmprss2	PRON
hls-10800	14	38	helps	help	VERB
hls-10800	14	39	to	to	ADP
hls-10800	14	40	virion	virion	NOUN
hls-10800	14	41	entry	entry	NOUN
hls-10800	14	42	and	and	CCONJ
hls-10800	14	43	the	the	DET
hls-10800	14	44	virion	virion	NOUN
hls-10800	14	45	releases	release	VERB
hls-10800	14	46	its	its	PRON
hls-10800	14	47	rna	rna	NOUN
hls-10800	14	48	.	.	PUNCT
hls-10800	15	1	rna	rna	PROPN
hls-10800	15	2	is	be	AUX
hls-10800	15	3	translated	translate	VERB
hls-10800	15	4	to	to	ADP
hls-10800	15	5	proteins	protein	NOUN
hls-10800	15	6	which	which	PRON
hls-10800	15	7	are	be	AUX
hls-10800	15	8	necessary	necessary	ADJ
hls-10800	15	9	for	for	ADP
hls-10800	15	10	the	the	DET
hls-10800	15	11	virion	virion	NOUN
hls-10800	15	12	and	and	CCONJ
hls-10800	15	13	finally	finally	ADV
hls-10800	15	14	the	the	DET
hls-10800	15	15	rna	rna	NOUN
hls-10800	15	16	is	be	AUX
hls-10800	15	17	assembled	assemble	VERB
hls-10800	15	18	into	into	ADP
hls-10800	15	19	a	a	DET
hls-10800	15	20	new	new	ADJ
hls-10800	15	21	virion	virion	NOUN
hls-10800	15	22	and	and	CCONJ
hls-10800	15	23	exits	exit	VERB
hls-10800	15	24	the	the	DET
hls-10800	15	25	cell.11	cell.11	ADJ
hls-10800	15	26	routes	route	NOUN
hls-10800	15	27	and	and	CCONJ
hls-10800	15	28	mechanism	mechanism	NOUN
hls-10800	15	29	of	of	ADP
hls-10800	15	30	cns	cns	NOUN
hls-10800	15	31	invasion	invasion	NOUN
hls-10800	15	32	as	as	SCONJ
hls-10800	15	33	mentioned	mention	VERB
hls-10800	15	34	above	above	ADV
hls-10800	15	35	,	,	PUNCT
hls-10800	15	36	evidence	evidence	NOUN
hls-10800	15	37	suggests	suggest	VERB
hls-10800	15	38	that	that	SCONJ
hls-10800	15	39	sars	sar	NOUN
hls-10800	15	40	-	-	PUNCT
hls-10800	15	41	cov-2	cov-2	PART
hls-10800	15	42	is	be	AUX
hls-10800	15	43	a	a	DET
hls-10800	15	44	neuroinvasive	neuroinvasive	ADJ
hls-10800	15	45	,	,	PUNCT
hls-10800	15	46	neurotropic	neurotropic	NOUN
hls-10800	15	47	,	,	PUNCT
hls-10800	15	48	and	and	CCONJ
hls-10800	15	49	neurovirulent	neurovirulent	ADJ
hls-10800	15	50	virus	virus	NOUN
hls-10800	15	51	to	to	ADP
hls-10800	15	52	both	both	DET
hls-10800	15	53	humans	human	NOUN
hls-10800	15	54	and	and	CCONJ
hls-10800	15	55	animals.12	animals.12	NOUN
hls-10800	15	56	because	because	SCONJ
hls-10800	15	57	ace2	ace2	PROPN
hls-10800	15	58	exists	exist	VERB
hls-10800	15	59	in	in	ADP
hls-10800	15	60	different	different	ADJ
hls-10800	15	61	human	human	ADJ
hls-10800	15	62	organs	organ	NOUN
hls-10800	15	63	such	such	ADJ
hls-10800	15	64	as	as	ADP
hls-10800	15	65	central	central	ADJ
hls-10800	15	66	nervous	nervous	ADJ
hls-10800	15	67	system	system	NOUN
hls-10800	15	68	(	(	PUNCT
hls-10800	15	69	cns	cns	NOUN
hls-10800	15	70	)	)	PUNCT
hls-10800	15	71	and	and	CCONJ
hls-10800	15	72	the	the	DET
hls-10800	15	73	endothelial	endothelial	ADJ
hls-10800	15	74	cells	cell	NOUN
hls-10800	15	75	,	,	PUNCT
hls-10800	15	76	interaction	interaction	NOUN
hls-10800	15	77	between	between	ADP
hls-10800	15	78	sars	sar	NOUN
hls-10800	15	79	-	-	PUNCT
hls-10800	15	80	cov-2	cov-2	PART
hls-10800	15	81	and	and	CCONJ
hls-10800	15	82	ace2	ace2	NOUN
hls-10800	15	83	receptors	receptor	NOUN
hls-10800	15	84	leads	lead	VERB
hls-10800	15	85	to	to	ADP
hls-10800	15	86	invasion	invasion	NOUN
hls-10800	15	87	into	into	ADP
hls-10800	15	88	the	the	DET
hls-10800	15	89	cns	cns	NOUN
hls-10800	15	90	through	through	ADP
hls-10800	15	91	different	different	ADJ
hls-10800	15	92	ways	way	NOUN
hls-10800	15	93	,	,	PUNCT
hls-10800	15	94	including	include	VERB
hls-10800	15	95	the	the	DET
hls-10800	15	96	olfactory	olfactory	NOUN
hls-10800	15	97	route	route	NOUN
hls-10800	15	98	,	,	PUNCT
hls-10800	15	99	the	the	DET
hls-10800	15	100	trans	trans	ADJ
hls-10800	15	101	-	-	ADJ
hls-10800	15	102	synaptic	synaptic	ADJ
hls-10800	15	103	route	route	NOUN
hls-10800	15	104	,	,	PUNCT
hls-10800	15	105	the	the	DET
hls-10800	15	106	leukocytic	leukocytic	ADJ
hls-10800	15	107	route	route	NOUN
hls-10800	15	108	and	and	CCONJ
hls-10800	15	109	the	the	DET
hls-10800	15	110	haematogenic	haematogenic	PROPN
hls-10800	15	111	route.13	route.13	PROPN
hls-10800	15	112	sars	sars	PROPN
hls-10800	15	113	-	-	PUNCT
hls-10800	15	114	cov-2	cov-2	NOUN
hls-10800	15	115	infects	infect	VERB
hls-10800	15	116	olfactory	olfactory	ADJ
hls-10800	15	117	epithelium	epithelium	NOUN
hls-10800	15	118	and	and	CCONJ
hls-10800	15	119	reaches	reach	VERB
hls-10800	15	120	the	the	DET
hls-10800	15	121	cns	cns	NOUN
hls-10800	15	122	via	via	ADP
hls-10800	15	123	the	the	DET
hls-10800	15	124	olfactory	olfactory	ADJ
hls-10800	15	125	neurons	neuron	NOUN
hls-10800	15	126	.	.	PUNCT
hls-10800	16	1	the	the	DET
hls-10800	16	2	high	high	ADJ
hls-10800	16	3	expression	expression	NOUN
hls-10800	16	4	of	of	ADP
hls-10800	16	5	ace2	ace2	PROPN
hls-10800	16	6	and	and	CCONJ
hls-10800	16	7	tmprss2	tmprss2	ADP
hls-10800	16	8	on	on	ADP
hls-10800	16	9	the	the	DET
hls-10800	16	10	olfactory	olfactory	NOUN
hls-10800	16	11	epithelium	epithelium	NOUN
hls-10800	16	12	has	have	VERB
hls-10800	16	13	a	a	DET
hls-10800	16	14	significant	significant	ADJ
hls-10800	16	15	role	role	NOUN
hls-10800	16	16	in	in	ADP
hls-10800	16	17	transferring	transfer	VERB
hls-10800	16	18	the	the	DET
hls-10800	16	19	virus	virus	NOUN
hls-10800	16	20	into	into	ADP
hls-10800	16	21	the	the	DET
hls-10800	16	22	cns	cns	NOUN
hls-10800	16	23	through	through	ADP
hls-10800	16	24	olfactory	olfactory	NOUN
hls-10800	16	25	neurons.14,15	neurons.14,15	VERB
hls-10800	16	26	the	the	DET
hls-10800	16	27	second	second	ADJ
hls-10800	16	28	rout	rout	NOUN
hls-10800	16	29	occurs	occur	VERB
hls-10800	16	30	when	when	SCONJ
hls-10800	16	31	sars	sar	NOUN
hls-10800	16	32	-	-	PUNCT
hls-10800	16	33	cov-2	cov-2	PART
hls-10800	16	34	infects	infect	VERB
hls-10800	16	35	peripheral	peripheral	ADJ
hls-10800	16	36	nerves	nerve	NOUN
hls-10800	16	37	and	and	CCONJ
hls-10800	16	38	the	the	DET
hls-10800	16	39	virus	virus	NOUN
hls-10800	16	40	uses	use	VERB
hls-10800	16	41	the	the	DET
hls-10800	16	42	axonal	axonal	ADJ
hls-10800	16	43	transport	transport	NOUN
hls-10800	16	44	machinery	machinery	NOUN
hls-10800	16	45	(	(	PUNCT
hls-10800	16	46	retrograde	retrograde	ADJ
hls-10800	16	47	transport	transport	NOUN
hls-10800	16	48	)	)	PUNCT
hls-10800	16	49	to	to	PART
hls-10800	16	50	access	access	VERB
hls-10800	16	51	the	the	DET
hls-10800	16	52	cns.16	cns.16	PROPN
hls-10800	16	53	the	the	DET
hls-10800	16	54	third	third	ADJ
hls-10800	16	55	route	route	NOUN
hls-10800	16	56	is	be	AUX
hls-10800	16	57	about	about	ADP
hls-10800	16	58	the	the	DET
hls-10800	16	59	role	role	NOUN
hls-10800	16	60	of	of	ADP
hls-10800	16	61	leukocytes	leukocyte	NOUN
hls-10800	16	62	.	.	PUNCT
hls-10800	17	1	coronavirus	coronavirus	NOUN
hls-10800	17	2	can	can	AUX
hls-10800	17	3	spread	spread	VERB
hls-10800	17	4	to	to	ADP
hls-10800	17	5	the	the	DET
hls-10800	17	6	cns	cns	NOUN
hls-10800	17	7	via	via	ADP
hls-10800	17	8	infected	infected	ADJ
hls-10800	17	9	immune	immune	ADJ
hls-10800	17	10	cells	cell	NOUN
hls-10800	17	11	,	,	PUNCT
hls-10800	17	12	such	such	ADJ
hls-10800	17	13	as	as	ADP
hls-10800	17	14	monocytes	monocyte	NOUN
hls-10800	17	15	,	,	PUNCT
hls-10800	17	16	neutrophils	neutrophil	NOUN
hls-10800	17	17	and	and	CCONJ
hls-10800	17	18	t	t	PROPN
hls-10800	17	19	cells.17	cells.17	VERB
hls-10800	17	20	some	some	DET
hls-10800	17	21	evidence	evidence	NOUN
hls-10800	17	22	shows	show	VERB
hls-10800	17	23	immune	immune	ADJ
hls-10800	17	24	cells	cell	NOUN
hls-10800	17	25	can	can	AUX
hls-10800	17	26	express	express	VERB
hls-10800	17	27	the	the	DET
hls-10800	17	28	binding	bind	VERB
hls-10800	17	29	receptors	receptor	NOUN
hls-10800	17	30	of	of	ADP
hls-10800	17	31	coronaviruses	coronaviruse	NOUN
hls-10800	17	32	.	.	PUNCT
hls-10800	18	1	so	so	ADV
hls-10800	18	2	they	they	PRON
hls-10800	18	3	serve	serve	VERB
hls-10800	18	4	as	as	SCONJ
hls-10800	18	5	the	the	DET
hls-10800	18	6	reservoirs	reservoir	NOUN
hls-10800	18	7	for	for	ADP
hls-10800	18	8	virus	virus	NOUN
hls-10800	18	9	particles.17,18	particles.17,18	NOUN
hls-10800	18	10	about	about	ADP
hls-10800	18	11	the	the	DET
hls-10800	18	12	fourth	fourth	ADJ
hls-10800	18	13	route	route	NOUN
hls-10800	18	14	is	be	AUX
hls-10800	18	15	assumed	assume	VERB
hls-10800	18	16	,	,	PUNCT
hls-10800	18	17	coronaviruses	coronaviruse	NOUN
hls-10800	18	18	can	can	AUX
hls-10800	18	19	attack	attack	VERB
hls-10800	18	20	ace2	ace2	NOUN
hls-10800	18	21	receptors	receptor	NOUN
hls-10800	18	22	on	on	ADP
hls-10800	18	23	the	the	DET
hls-10800	18	24	endothelial	endothelial	ADJ
hls-10800	18	25	cells	cell	NOUN
hls-10800	18	26	of	of	ADP
hls-10800	18	27	brain	brain	NOUN
hls-10800	18	28	vessels	vessel	NOUN
hls-10800	18	29	that	that	PRON
hls-10800	18	30	cause	cause	VERB
hls-10800	18	31	disruption	disruption	NOUN
hls-10800	18	32	in	in	ADP
hls-10800	18	33	bbb	bbb	PROPN
hls-10800	18	34	and	and	CCONJ
hls-10800	18	35	viruses	virus	NOUN
hls-10800	18	36	spread	spread	VERB
hls-10800	18	37	into	into	ADP
hls-10800	18	38	the	the	DET
hls-10800	18	39	cns.19	cns.19	NOUN
hls-10800	18	40	the	the	DET
hls-10800	18	41	most	most	ADV
hls-10800	18	42	important	important	ADJ
hls-10800	18	43	injuries	injury	NOUN
hls-10800	18	44	in	in	ADP
hls-10800	18	45	cov	cov	PROPN
hls-10800	18	46	hypoxia	hypoxia	NOUN
hls-10800	18	47	many	many	ADJ
hls-10800	18	48	problems	problem	NOUN
hls-10800	18	49	such	such	ADJ
hls-10800	18	50	as	as	ADP
hls-10800	18	51	hemorrhagic	hemorrhagic	NOUN
hls-10800	18	52	problems	problem	NOUN
hls-10800	18	53	or	or	CCONJ
hls-10800	18	54	infections	infection	NOUN
hls-10800	18	55	can	can	AUX
hls-10800	18	56	lead	lead	VERB
hls-10800	18	57	to	to	ADP
hls-10800	18	58	brain	brain	NOUN
hls-10800	18	59	hypoxia	hypoxia	NOUN
hls-10800	18	60	.	.	PUNCT
hls-10800	19	1	proliferation	proliferation	NOUN
hls-10800	19	2	of	of	ADP
hls-10800	19	3	virus	virus	NOUN
hls-10800	19	4	in	in	ADP
hls-10800	19	5	lung	lung	NOUN
hls-10800	19	6	cells	cell	NOUN
hls-10800	19	7	is	be	AUX
hls-10800	19	8	accompanied	accompany	VERB
hls-10800	19	9	by	by	ADP
hls-10800	19	10	alveolar	alveolar	ADJ
hls-10800	19	11	gas	gas	NOUN
hls-10800	19	12	exchange	exchange	NOUN
hls-10800	19	13	disorders	disorder	NOUN
hls-10800	19	14	,	,	PUNCT
hls-10800	19	15	which	which	PRON
hls-10800	19	16	cause	cause	VERB
hls-10800	19	17	hypoxia	hypoxia	NOUN
hls-10800	19	18	in	in	ADP
hls-10800	19	19	the	the	DET
hls-10800	19	20	brain	brain	NOUN
hls-10800	19	21	via	via	ADP
hls-10800	19	22	enhancing	enhance	VERB
hls-10800	19	23	anaerobic	anaerobic	ADJ
hls-10800	19	24	metabolism	metabolism	NOUN
hls-10800	19	25	in	in	ADP
hls-10800	19	26	the	the	DET
hls-10800	19	27	brain	brain	NOUN
hls-10800	19	28	cells	cell	NOUN
hls-10800	19	29	’	'	PUNCT
hls-10800	19	30	mitochondria.20	mitochondria.20	NOUN
hls-10800	19	31	hypoxia	hypoxia	NOUN
hls-10800	19	32	in	in	ADP
hls-10800	19	33	the	the	DET
hls-10800	19	34	brain	brain	NOUN
hls-10800	19	35	subsequently	subsequently	ADV
hls-10800	19	36	causes	cause	VERB
hls-10800	19	37	edema	edema	PROPN
hls-10800	19	38	in	in	ADP
hls-10800	19	39	brain	brain	NOUN
hls-10800	19	40	cells	cell	NOUN
hls-10800	19	41	,	,	PUNCT
hls-10800	19	42	cerebral	cerebral	ADJ
hls-10800	19	43	vasodilation	vasodilation	NOUN
hls-10800	19	44	,	,	PUNCT
hls-10800	19	45	cerebral	cerebral	ADJ
hls-10800	19	46	blood	blood	NOUN
hls-10800	19	47	healthcare	healthcare	NOUN
hls-10800	19	48	in	in	ADP
hls-10800	19	49	low	low	ADJ
hls-10800	19	50	-	-	PUNCT
hls-10800	19	51	resource	resource	NOUN
hls-10800	19	52	settings	setting	NOUN
hls-10800	19	53	2022	2022	NUM
hls-10800	19	54	;	;	PUNCT
hls-10800	19	55	volume	volume	NOUN
hls-10800	19	56	10:10800	10:10800	NUM
hls-10800	19	57	correspondence	correspondence	NOUN
hls-10800	19	58	:	:	PUNCT
hls-10800	19	59	feryal	feryal	ADJ
hls-10800	19	60	dabagh	dabagh	PROPN
hls-10800	19	61	-	-	PUNCT
hls-10800	19	62	gorjani	gorjani	NOUN
hls-10800	19	63	,	,	PUNCT
hls-10800	19	64	department	department	NOUN
hls-10800	19	65	of	of	ADP
hls-10800	19	66	immunology	immunology	NOUN
hls-10800	19	67	,	,	PUNCT
hls-10800	19	68	school	school	NOUN
hls-10800	19	69	of	of	ADP
hls-10800	19	70	medicine	medicine	NOUN
hls-10800	19	71	,	,	PUNCT
hls-10800	19	72	shiraz	shiraz	PROPN
hls-10800	19	73	university	university	PROPN
hls-10800	19	74	of	of	ADP
hls-10800	19	75	medical	medical	ADJ
hls-10800	19	76	sciences	sciences	PROPN
hls-10800	19	77	,	,	PUNCT
hls-10800	19	78	shiraz	shiraz	PROPN
hls-10800	19	79	,	,	PUNCT
hls-10800	19	80	iran	iran	PROPN
hls-10800	19	81	.	.	PUNCT
hls-10800	20	1	tel	tel	ADP
hls-10800	20	2	:	:	PUNCT
hls-10800	20	3	:	:	PUNCT
hls-10800	20	4	+989126306762	+989126306762	NUM
hls-10800	20	5	e	e	NOUN
hls-10800	20	6	-	-	NOUN
hls-10800	20	7	mail	mail	NOUN
hls-10800	20	8	:	:	PUNCT
hls-10800	21	1	dabaghferyal@gmail.com	dabaghferyal@gmail.com	X
hls-10800	21	2	key	key	ADJ
hls-10800	21	3	words	word	NOUN
hls-10800	21	4	:	:	PUNCT
hls-10800	21	5	covid-19	covid-19	PROPN
hls-10800	21	6	;	;	PUNCT
hls-10800	21	7	inflammation	inflammation	NOUN
hls-10800	21	8	;	;	PUNCT
hls-10800	21	9	neurodegeneration	neurodegeneration	NOUN
hls-10800	21	10	;	;	PUNCT
hls-10800	21	11	immune	immune	ADJ
hls-10800	21	12	system	system	NOUN
hls-10800	21	13	;	;	PUNCT
hls-10800	21	14	cytokine	cytokine	NOUN
hls-10800	21	15	storm	storm	NOUN
hls-10800	21	16	.	.	PUNCT
hls-10800	22	1	contributions	contribution	NOUN
hls-10800	22	2	:	:	PUNCT
hls-10800	22	3	fdg	fdg	PROPN
hls-10800	22	4	carried	carry	VERB
hls-10800	22	5	out	out	ADP
hls-10800	22	6	the	the	DET
hls-10800	22	7	design	design	NOUN
hls-10800	22	8	,	,	PUNCT
hls-10800	22	9	literature	literature	NOUN
hls-10800	22	10	survey	survey	NOUN
hls-10800	22	11	,	,	PUNCT
hls-10800	22	12	writing	writing	NOUN
hls-10800	22	13	and	and	CCONJ
hls-10800	22	14	revision	revision	NOUN
hls-10800	22	15	of	of	ADP
hls-10800	22	16	the	the	DET
hls-10800	22	17	manuscript	manuscript	NOUN
hls-10800	22	18	;	;	PUNCT
hls-10800	22	19	maf	maf	NOUN
hls-10800	22	20	collected	collect	VERB
hls-10800	22	21	the	the	DET
hls-10800	22	22	data	datum	NOUN
hls-10800	22	23	and	and	CCONJ
hls-10800	22	24	articles	article	NOUN
hls-10800	22	25	and	and	CCONJ
hls-10800	22	26	provided	provide	VERB
hls-10800	22	27	critical	critical	ADJ
hls-10800	22	28	feedback	feedback	NOUN
hls-10800	22	29	on	on	ADP
hls-10800	22	30	the	the	DET
hls-10800	22	31	manuscript	manuscript	NOUN
hls-10800	22	32	.	.	PUNCT
hls-10800	23	1	conflict	conflict	NOUN
hls-10800	23	2	of	of	ADP
hls-10800	23	3	interest	interest	NOUN
hls-10800	23	4	:	:	PUNCT
hls-10800	23	5	the	the	DET
hls-10800	23	6	authors	author	NOUN
hls-10800	23	7	declare	declare	VERB
hls-10800	23	8	no	no	DET
hls-10800	23	9	conflict	conflict	NOUN
hls-10800	23	10	of	of	ADP
hls-10800	23	11	interest	interest	NOUN
hls-10800	23	12	.	.	PUNCT
hls-10800	24	1	funding	funding	NOUN
hls-10800	24	2	:	:	PUNCT
hls-10800	24	3	none	none	NOUN
hls-10800	24	4	.	.	PUNCT
hls-10800	25	1	availability	availability	NOUN
hls-10800	25	2	of	of	ADP
hls-10800	25	3	data	datum	NOUN
hls-10800	25	4	and	and	CCONJ
hls-10800	25	5	materials	material	NOUN
hls-10800	25	6	:	:	PUNCT
hls-10800	25	7	the	the	DET
hls-10800	25	8	authors	author	NOUN
hls-10800	25	9	confirm	confirm	VERB
hls-10800	25	10	that	that	SCONJ
hls-10800	25	11	the	the	DET
hls-10800	25	12	data	datum	NOUN
hls-10800	25	13	supporting	support	VERB
hls-10800	25	14	the	the	DET
hls-10800	25	15	findings	finding	NOUN
hls-10800	25	16	of	of	ADP
hls-10800	25	17	this	this	DET
hls-10800	25	18	study	study	NOUN
hls-10800	25	19	are	be	AUX
hls-10800	25	20	available	available	ADJ
hls-10800	25	21	within	within	ADP
hls-10800	25	22	the	the	DET
hls-10800	25	23	article	article	NOUN
hls-10800	25	24	.	.	PUNCT
hls-10800	26	1	ethics	ethic	NOUN
hls-10800	26	2	approval	approval	NOUN
hls-10800	26	3	and	and	CCONJ
hls-10800	26	4	consent	consent	NOUN
hls-10800	26	5	to	to	PART
hls-10800	26	6	participate	participate	VERB
hls-10800	26	7	:	:	PUNCT
hls-10800	26	8	not	not	PART
hls-10800	26	9	applicable	applicable	ADJ
hls-10800	26	10	.	.	PUNCT
hls-10800	27	1	informed	informed	ADJ
hls-10800	27	2	consent	consent	NOUN
hls-10800	27	3	:	:	PUNCT
hls-10800	27	4	not	not	PART
hls-10800	27	5	applicable	applicable	ADJ
hls-10800	27	6	.	.	PUNCT
hls-10800	28	1	received	receive	VERB
hls-10800	28	2	for	for	ADP
hls-10800	28	3	publication	publication	NOUN
hls-10800	28	4	:	:	PUNCT
hls-10800	28	5	13	13	NUM
hls-10800	28	6	august	august	PROPN
hls-10800	28	7	2022	2022	NUM
hls-10800	28	8	.	.	PUNCT
hls-10800	29	1	revision	revision	NOUN
hls-10800	29	2	received	receive	VERB
hls-10800	29	3	:	:	PUNCT
hls-10800	29	4	14	14	NUM
hls-10800	29	5	november	november	PROPN
hls-10800	29	6	2022	2022	NUM
hls-10800	29	7	.	.	PUNCT
hls-10800	30	1	accepted	accept	VERB
hls-10800	30	2	for	for	ADP
hls-10800	30	3	publication	publication	NOUN
hls-10800	30	4	:	:	PUNCT
hls-10800	30	5	14	14	NUM
hls-10800	30	6	november	november	PROPN
hls-10800	30	7	2022	2022	NUM
hls-10800	30	8	.	.	PUNCT
hls-10800	31	1	this	this	DET
hls-10800	31	2	work	work	NOUN
hls-10800	31	3	is	be	AUX
hls-10800	31	4	licensed	license	VERB
hls-10800	31	5	under	under	ADP
hls-10800	31	6	a	a	DET
hls-10800	31	7	creative	creative	ADJ
hls-10800	31	8	commons	common	NOUN
hls-10800	31	9	attribution	attribution	NOUN
hls-10800	31	10	4.0	4.0	NUM
hls-10800	31	11	license	license	NOUN
hls-10800	31	12	(	(	PUNCT
hls-10800	31	13	by	by	ADP
hls-10800	31	14	-	-	PUNCT
hls-10800	31	15	nc	nc	PROPN
hls-10800	31	16	4.0	4.0	NUM
hls-10800	31	17	)	)	PUNCT
hls-10800	31	18	.	.	PUNCT
hls-10800	32	1	©	©	PROPN
hls-10800	32	2	copyright	copyright	NOUN
hls-10800	32	3	:	:	PUNCT
hls-10800	32	4	the	the	DET
hls-10800	32	5	author(s	author(s	PROPN
hls-10800	32	6	)	)	PUNCT
hls-10800	32	7	,	,	PUNCT
hls-10800	32	8	2022	2022	NUM
hls-10800	32	9	licensee	licensee	NOUN
hls-10800	32	10	pagepress	pagepress	NOUN
hls-10800	32	11	,	,	PUNCT
hls-10800	32	12	italy	italy	PROPN
hls-10800	32	13	healthcare	healthcare	PROPN
hls-10800	32	14	in	in	ADP
hls-10800	32	15	low	low	ADJ
hls-10800	32	16	-	-	PUNCT
hls-10800	32	17	resource	resource	NOUN
hls-10800	32	18	settings	setting	NOUN
hls-10800	32	19	2022	2022	NUM
hls-10800	32	20	;	;	PUNCT
hls-10800	32	21	10:10800	10:10800	NUM
hls-10800	32	22	doi:10.4081	doi:10.4081	ADJ
hls-10800	32	23	/	/	SYM
hls-10800	32	24	hls.2022.10800	hls.2022.10800	PROPN
hls-10800	32	25	publisher	publisher	NOUN
hls-10800	32	26	's	's	PART
hls-10800	32	27	note	note	NOUN
hls-10800	32	28	:	:	PUNCT
hls-10800	32	29	all	all	DET
hls-10800	32	30	claims	claim	NOUN
hls-10800	32	31	expressed	express	VERB
hls-10800	32	32	in	in	ADP
hls-10800	32	33	this	this	DET
hls-10800	32	34	article	article	NOUN
hls-10800	32	35	are	be	AUX
hls-10800	32	36	solely	solely	ADV
hls-10800	32	37	those	those	PRON
hls-10800	32	38	of	of	ADP
hls-10800	32	39	the	the	DET
hls-10800	32	40	authors	author	NOUN
hls-10800	32	41	and	and	CCONJ
hls-10800	32	42	do	do	AUX
hls-10800	32	43	not	not	PART
hls-10800	32	44	necessarily	necessarily	ADV
hls-10800	32	45	represent	represent	VERB
hls-10800	32	46	those	those	PRON
hls-10800	32	47	of	of	ADP
hls-10800	32	48	their	their	PRON
hls-10800	32	49	affiliated	affiliated	ADJ
hls-10800	32	50	organizations	organization	NOUN
hls-10800	32	51	,	,	PUNCT
hls-10800	32	52	or	or	CCONJ
hls-10800	32	53	those	those	PRON
hls-10800	32	54	of	of	ADP
hls-10800	32	55	the	the	DET
hls-10800	32	56	publisher	publisher	NOUN
hls-10800	32	57	,	,	PUNCT
hls-10800	32	58	the	the	DET
hls-10800	32	59	editors	editor	NOUN
hls-10800	32	60	and	and	CCONJ
hls-10800	32	61	the	the	DET
hls-10800	32	62	reviewers	reviewer	NOUN
hls-10800	32	63	.	.	PUNCT
hls-10800	33	1	any	any	DET
hls-10800	33	2	product	product	NOUN
hls-10800	33	3	that	that	PRON
hls-10800	33	4	may	may	AUX
hls-10800	33	5	be	be	AUX
hls-10800	33	6	evaluated	evaluate	VERB
hls-10800	33	7	in	in	ADP
hls-10800	33	8	this	this	DET
hls-10800	33	9	article	article	NOUN
hls-10800	33	10	or	or	CCONJ
hls-10800	33	11	claim	claim	NOUN
hls-10800	33	12	that	that	PRON
hls-10800	33	13	may	may	AUX
hls-10800	33	14	be	be	AUX
hls-10800	33	15	made	make	VERB
hls-10800	33	16	by	by	ADP
hls-10800	33	17	its	its	PRON
hls-10800	33	18	manufacturer	manufacturer	NOUN
hls-10800	33	19	is	be	AUX
hls-10800	33	20	not	not	PART
hls-10800	33	21	guaranteed	guarantee	VERB
hls-10800	33	22	or	or	CCONJ
hls-10800	33	23	endorsed	endorse	VERB
hls-10800	33	24	by	by	ADP
hls-10800	33	25	the	the	DET
hls-10800	33	26	publisher.non	publisher.non	X
hls-10800	33	27	-co	-co	CCONJ
hls-10800	33	28	mmerc	mmerc	PROPN
hls-10800	33	29	ial	ial	PROPN
hls-10800	34	1	us	us	PROPN
hls-10800	34	2	e	e	NOUN
hls-10800	34	3	o	o	NOUN
hls-10800	35	1	nly	nly	ADV
hls-10800	35	2	[	[	X
hls-10800	35	3	page	page	NOUN
hls-10800	35	4	62	62	NUM
hls-10800	35	5	]	]	PUNCT
hls-10800	36	1	[	[	X
hls-10800	36	2	healthcare	healthcare	NOUN
hls-10800	36	3	in	in	ADP
hls-10800	36	4	low	low	ADJ
hls-10800	36	5	-	-	PUNCT
hls-10800	36	6	resource	resource	NOUN
hls-10800	36	7	settings	setting	NOUN
hls-10800	36	8	2022	2022	NUM
hls-10800	36	9	;	;	PUNCT
hls-10800	36	10	10:10800	10:10800	NUM
hls-10800	36	11	]	]	PUNCT
hls-10800	36	12	flow	flow	NOUN
hls-10800	36	13	impediment	impediment	NOUN
hls-10800	36	14	and	and	CCONJ
hls-10800	36	15	headache	headache	NOUN
hls-10800	36	16	.	.	PUNCT
hls-10800	37	1	if	if	SCONJ
hls-10800	37	2	hypoxia	hypoxia	NOUN
hls-10800	37	3	continues	continue	VERB
hls-10800	37	4	,	,	PUNCT
hls-10800	37	5	brain	brain	NOUN
hls-10800	37	6	function	function	NOUN
hls-10800	37	7	will	will	AUX
hls-10800	37	8	be	be	AUX
hls-10800	37	9	reduced	reduce	VERB
hls-10800	37	10	and	and	CCONJ
hls-10800	37	11	drowsiness	drowsiness	NOUN
hls-10800	37	12	,	,	PUNCT
hls-10800	37	13	bulbar	bulbar	ADJ
hls-10800	37	14	conjunctival	conjunctival	NOUN
hls-10800	37	15	edema	edema	NOUN
hls-10800	37	16	and	and	CCONJ
hls-10800	37	17	more	more	ADV
hls-10800	37	18	complex	complex	ADJ
hls-10800	37	19	problems	problem	NOUN
hls-10800	37	20	like	like	ADP
hls-10800	37	21	coma	coma	NOUN
hls-10800	37	22	can	can	AUX
hls-10800	37	23	be	be	AUX
hls-10800	37	24	observed.20	observed.20	NOUN
hls-10800	37	25	hypoxia	hypoxia	NOUN
hls-10800	37	26	may	may	AUX
hls-10800	37	27	also	also	ADV
hls-10800	37	28	cause	cause	VERB
hls-10800	37	29	acute	acute	ADJ
hls-10800	37	30	cerebrovascular	cerebrovascular	ADJ
hls-10800	37	31	disease	disease	NOUN
hls-10800	37	32	such	such	ADJ
hls-10800	37	33	as	as	ADP
hls-10800	37	34	acute	acute	ADJ
hls-10800	37	35	ischemic	ischemic	ADJ
hls-10800	37	36	stroke	stroke	NOUN
hls-10800	37	37	in	in	ADP
hls-10800	37	38	a	a	DET
hls-10800	37	39	patient	patient	NOUN
hls-10800	37	40	.	.	PUNCT
hls-10800	38	1	as	as	SCONJ
hls-10800	38	2	patients	patient	NOUN
hls-10800	38	3	with	with	ADP
hls-10800	38	4	covid-19	covid-19	PROPN
hls-10800	38	5	often	often	ADV
hls-10800	38	6	suffer	suffer	VERB
hls-10800	38	7	from	from	ADP
hls-10800	38	8	severe	severe	ADJ
hls-10800	38	9	hypoxia,21	hypoxia,21	NOUN
hls-10800	38	10	this	this	PRON
hls-10800	38	11	may	may	AUX
hls-10800	38	12	lead	lead	VERB
hls-10800	38	13	to	to	ADP
hls-10800	38	14	subsequent	subsequent	ADJ
hls-10800	38	15	nervous	nervous	ADJ
hls-10800	38	16	system	system	NOUN
hls-10800	38	17	damage	damage	NOUN
hls-10800	38	18	.	.	PUNCT
hls-10800	39	1	immune	immune	ADJ
hls-10800	39	2	injury	injury	NOUN
hls-10800	39	3	high	high	ADJ
hls-10800	39	4	levels	level	NOUN
hls-10800	39	5	of	of	ADP
hls-10800	39	6	il-1β	il-1β	PROPN
hls-10800	39	7	,	,	PUNCT
hls-10800	39	8	il-2	il-2	NUM
hls-10800	39	9	,	,	PUNCT
hls-10800	39	10	il-6	il-6	PRON
hls-10800	39	11	,	,	PUNCT
hls-10800	39	12	il-7	il-7	X
hls-10800	39	13	,	,	PUNCT
hls-10800	39	14	il-8	il-8	NOUN
hls-10800	39	15	,	,	PUNCT
hls-10800	39	16	il-10	il-10	PRON
hls-10800	39	17	,	,	PUNCT
hls-10800	39	18	il-17	il-17	X
hls-10800	39	19	,	,	PUNCT
hls-10800	39	20	inf	inf	NOUN
hls-10800	39	21	-	-	PUNCT
hls-10800	39	22	γ	γ	PROPN
hls-10800	39	23	,	,	PUNCT
hls-10800	39	24	mcp1	mcp1	PROPN
hls-10800	39	25	,	,	PUNCT
hls-10800	39	26	g	g	NOUN
hls-10800	39	27	-	-	PUNCT
hls-10800	39	28	csf	csf	ADJ
hls-10800	39	29	,	,	PUNCT
hls-10800	39	30	tnfα	tnfα	NOUN
hls-10800	39	31	,	,	PUNCT
hls-10800	39	32	and	and	CCONJ
hls-10800	39	33	macrophages	macrophage	VERB
hls-10800	39	34	inflammatory	inflammatory	ADJ
hls-10800	39	35	protein	protein	NOUN
hls-10800	39	36	1α	1α	NOUN
hls-10800	39	37	were	be	AUX
hls-10800	39	38	seen	see	VERB
hls-10800	39	39	in	in	ADP
hls-10800	39	40	patient	patient	NOUN
hls-10800	39	41	with	with	ADP
hls-10800	39	42	covid19.22	covid19.22	NOUN
hls-10800	39	43	on	on	ADP
hls-10800	39	44	the	the	DET
hls-10800	39	45	other	other	ADJ
hls-10800	39	46	hand	hand	NOUN
hls-10800	39	47	,	,	PUNCT
hls-10800	39	48	neurotropic	neurotropic	ADJ
hls-10800	39	49	viruses	virus	NOUN
hls-10800	39	50	can	can	AUX
hls-10800	39	51	lead	lead	VERB
hls-10800	39	52	to	to	ADP
hls-10800	39	53	brain	brain	NOUN
hls-10800	39	54	damage	damage	NOUN
hls-10800	39	55	and	and	CCONJ
hls-10800	39	56	chronic	chronic	ADJ
hls-10800	39	57	inflammation	inflammation	NOUN
hls-10800	39	58	via	via	ADP
hls-10800	39	59	the	the	DET
hls-10800	39	60	activation	activation	NOUN
hls-10800	39	61	of	of	ADP
hls-10800	39	62	glial	glial	ADJ
hls-10800	39	63	cells	cell	NOUN
hls-10800	39	64	.	.	PUNCT
hls-10800	40	1	glial	glial	ADJ
hls-10800	40	2	cells	cell	NOUN
hls-10800	40	3	,	,	PUNCT
hls-10800	40	4	by	by	ADP
hls-10800	40	5	producing	produce	VERB
hls-10800	40	6	high	high	ADJ
hls-10800	40	7	levels	level	NOUN
hls-10800	40	8	of	of	ADP
hls-10800	40	9	inflammatory	inflammatory	ADJ
hls-10800	40	10	factors	factor	NOUN
hls-10800	40	11	,	,	PUNCT
hls-10800	40	12	such	such	ADJ
hls-10800	40	13	as	as	ADP
hls-10800	40	14	cytokines	cytokine	NOUN
hls-10800	40	15	,	,	PUNCT
hls-10800	40	16	chemokines	chemokine	NOUN
hls-10800	40	17	,	,	PUNCT
hls-10800	40	18	and	and	CCONJ
hls-10800	40	19	other	other	ADJ
hls-10800	40	20	inflammation	inflammation	NOUN
hls-10800	40	21	signals	signal	NOUN
hls-10800	40	22	,	,	PUNCT
hls-10800	40	23	enhance	enhance	VERB
hls-10800	40	24	brain	brain	NOUN
hls-10800	40	25	damage	damage	NOUN
hls-10800	40	26	.	.	PUNCT
hls-10800	41	1	cytokine	cytokine	ADJ
hls-10800	41	2	storms	storm	NOUN
hls-10800	41	3	cause	cause	VERB
hls-10800	41	4	disruption	disruption	NOUN
hls-10800	41	5	to	to	ADP
hls-10800	41	6	the	the	DET
hls-10800	41	7	integrity	integrity	NOUN
hls-10800	41	8	of	of	ADP
hls-10800	41	9	bbb	bbb	PROPN
hls-10800	41	10	,	,	PUNCT
hls-10800	41	11	which	which	PRON
hls-10800	41	12	provokes	provoke	VERB
hls-10800	41	13	the	the	DET
hls-10800	41	14	neuro	neuro	NOUN
hls-10800	41	15	inflammatory	inflammatory	ADJ
hls-10800	41	16	process.23	process.23	NOUN
hls-10800	41	17	additionally	additionally	ADV
hls-10800	41	18	,	,	PUNCT
hls-10800	41	19	studies	study	NOUN
hls-10800	41	20	showed	show	VERB
hls-10800	41	21	there	there	PRON
hls-10800	41	22	is	be	VERB
hls-10800	41	23	a	a	DET
hls-10800	41	24	positive	positive	ADJ
hls-10800	41	25	correlation	correlation	NOUN
hls-10800	41	26	between	between	ADP
hls-10800	41	27	il-6	il-6	NOUN
hls-10800	41	28	and	and	CCONJ
hls-10800	41	29	the	the	DET
hls-10800	41	30	severity	severity	NOUN
hls-10800	41	31	of	of	ADP
hls-10800	41	32	covid-2019	covid-2019	ADJ
hls-10800	41	33	symptoms.24	symptoms.24	DET
hls-10800	41	34	activation	activation	NOUN
hls-10800	41	35	of	of	ADP
hls-10800	41	36	immune	immune	ADJ
hls-10800	41	37	cells	cell	NOUN
hls-10800	41	38	in	in	ADP
hls-10800	41	39	the	the	DET
hls-10800	41	40	brain	brain	NOUN
hls-10800	41	41	will	will	AUX
hls-10800	41	42	cause	cause	VERB
hls-10800	41	43	chronic	chronic	ADJ
hls-10800	41	44	inflammation	inflammation	NOUN
hls-10800	41	45	and	and	CCONJ
hls-10800	41	46	brain	brain	NOUN
hls-10800	41	47	damage	damage	NOUN
hls-10800	41	48	.	.	PUNCT
hls-10800	42	1	cognition	cognition	NOUN
hls-10800	42	2	impairment	impairment	VERB
hls-10800	42	3	clinical	clinical	ADJ
hls-10800	42	4	and	and	CCONJ
hls-10800	42	5	preclinical	preclinical	ADJ
hls-10800	42	6	studies	study	NOUN
hls-10800	42	7	suggest	suggest	VERB
hls-10800	42	8	that	that	SCONJ
hls-10800	42	9	bacterial	bacterial	ADJ
hls-10800	42	10	,	,	PUNCT
hls-10800	42	11	viral	viral	ADJ
hls-10800	42	12	,	,	PUNCT
hls-10800	42	13	and	and	CCONJ
hls-10800	42	14	toxic	toxic	ADJ
hls-10800	42	15	inflammation	inflammation	NOUN
hls-10800	42	16	can	can	AUX
hls-10800	42	17	activate	activate	VERB
hls-10800	42	18	toll	toll	NOUN
hls-10800	42	19	-	-	PUNCT
hls-10800	42	20	like	like	ADJ
hls-10800	42	21	receptors	receptor	NOUN
hls-10800	42	22	in	in	ADP
hls-10800	42	23	microglia	microglia	ADJ
hls-10800	42	24	and	and	CCONJ
hls-10800	42	25	astrocytes	astrocyte	NOUN
hls-10800	42	26	,	,	PUNCT
hls-10800	42	27	and	and	CCONJ
hls-10800	42	28	finally	finally	ADV
hls-10800	42	29	cause	cause	VERB
hls-10800	42	30	neuro	neuro	PROPN
hls-10800	42	31	inflammation	inflammation	NOUN
hls-10800	42	32	that	that	PRON
hls-10800	42	33	may	may	AUX
hls-10800	42	34	lead	lead	VERB
hls-10800	42	35	to	to	ADP
hls-10800	42	36	neuronal	neuronal	ADJ
hls-10800	42	37	death	death	NOUN
hls-10800	42	38	and	and	CCONJ
hls-10800	42	39	cognitive	cognitive	ADJ
hls-10800	42	40	impairments.25	impairments.25	NOUN
hls-10800	42	41	neuro	neuro	PROPN
hls-10800	42	42	inflammation	inflammation	NOUN
hls-10800	42	43	induced	induce	VERB
hls-10800	42	44	by	by	ADP
hls-10800	42	45	prolonged	prolonged	ADJ
hls-10800	42	46	hypoxia	hypoxia	NOUN
hls-10800	42	47	and	and	CCONJ
hls-10800	42	48	systemic	systemic	ADJ
hls-10800	42	49	inflammation	inflammation	NOUN
hls-10800	42	50	lead	lead	NOUN
hls-10800	42	51	to	to	AUX
hls-10800	42	52	damage	damage	NOUN
hls-10800	42	53	in	in	ADP
hls-10800	42	54	brain	brain	NOUN
hls-10800	42	55	regions	region	NOUN
hls-10800	42	56	responsible	responsible	ADJ
hls-10800	42	57	for	for	ADP
hls-10800	42	58	cognitive	cognitive	ADJ
hls-10800	42	59	functions	function	NOUN
hls-10800	42	60	and	and	CCONJ
hls-10800	42	61	behavioral	behavioral	ADJ
hls-10800	42	62	alterations	alteration	NOUN
hls-10800	42	63	,	,	PUNCT
hls-10800	42	64	such	such	ADJ
hls-10800	42	65	as	as	ADP
hls-10800	42	66	the	the	DET
hls-10800	42	67	hippocampus	hippocampus	NOUN
hls-10800	42	68	and	and	CCONJ
hls-10800	42	69	cortex.26	cortex.26	ADJ
hls-10800	42	70	delirium	delirium	NOUN
hls-10800	42	71	as	as	ADP
hls-10800	42	72	functional	functional	ADJ
hls-10800	42	73	brain	brain	NOUN
hls-10800	42	74	damage	damage	NOUN
hls-10800	42	75	is	be	AUX
hls-10800	42	76	commonly	commonly	ADV
hls-10800	42	77	activated	activate	VERB
hls-10800	42	78	by	by	ADP
hls-10800	42	79	peripheral	peripheral	ADJ
hls-10800	42	80	infection	infection	NOUN
hls-10800	42	81	associated	associate	VERB
hls-10800	42	82	with	with	ADP
hls-10800	42	83	systemic	systemic	ADJ
hls-10800	42	84	inflammation	inflammation	NOUN
hls-10800	42	85	and	and	CCONJ
hls-10800	42	86	is	be	AUX
hls-10800	42	87	accompanied	accompany	VERB
hls-10800	42	88	by	by	ADP
hls-10800	42	89	an	an	DET
hls-10800	42	90	elevated	elevated	ADJ
hls-10800	42	91	level	level	NOUN
hls-10800	42	92	of	of	ADP
hls-10800	42	93	serum	serum	NOUN
hls-10800	42	94	pro	pro	ADJ
hls-10800	42	95	-	-	NOUN
hls-10800	42	96	interleukins	interleukin	NOUN
hls-10800	42	97	and	and	CCONJ
hls-10800	42	98	s100b	s100b	PROPN
hls-10800	42	99	(	(	PUNCT
hls-10800	42	100	as	as	ADP
hls-10800	42	101	an	an	DET
hls-10800	42	102	index	index	NOUN
hls-10800	42	103	for	for	ADP
hls-10800	42	104	bbb	bbb	NOUN
hls-10800	42	105	disruption	disruption	NOUN
hls-10800	42	106	)	)	PUNCT
hls-10800	42	107	in	in	ADP
hls-10800	42	108	elderly	elderly	ADJ
hls-10800	42	109	patients.27	patients.27	PROPN
hls-10800	42	110	neuro	neuro	PROPN
hls-10800	42	111	inflammation	inflammation	NOUN
hls-10800	42	112	has	have	AUX
hls-10800	42	113	been	be	AUX
hls-10800	42	114	implied	imply	VERB
hls-10800	42	115	as	as	ADP
hls-10800	42	116	an	an	DET
hls-10800	42	117	important	important	ADJ
hls-10800	42	118	factor	factor	NOUN
hls-10800	42	119	in	in	ADP
hls-10800	42	120	neurodegenerative	neurodegenerative	ADJ
hls-10800	42	121	disorders28	disorders28	ADJ
hls-10800	42	122	and	and	CCONJ
hls-10800	42	123	psychiatric	psychiatric	ADJ
hls-10800	42	124	pathologies	pathology	NOUN
hls-10800	42	125	,	,	PUNCT
hls-10800	42	126	including	include	VERB
hls-10800	42	127	acute	acute	ADJ
hls-10800	42	128	psychosis	psychosis	NOUN
hls-10800	42	129	,	,	PUNCT
hls-10800	42	130	schizophrenia	schizophrenia	NOUN
hls-10800	42	131	,	,	PUNCT
hls-10800	42	132	and	and	CCONJ
hls-10800	42	133	autism	autism	NOUN
hls-10800	42	134	spectrum	spectrum	VERB
hls-10800	42	135	disorder.29	disorder.29	PROPN
hls-10800	42	136	some	some	DET
hls-10800	42	137	evidence	evidence	NOUN
hls-10800	42	138	showed	show	VERB
hls-10800	42	139	that	that	SCONJ
hls-10800	42	140	anxiety	anxiety	NOUN
hls-10800	42	141	and	and	CCONJ
hls-10800	42	142	depression	depression	NOUN
hls-10800	42	143	increased	increase	VERB
hls-10800	42	144	in	in	ADP
hls-10800	42	145	patients	patient	NOUN
hls-10800	42	146	with	with	ADP
hls-10800	42	147	covid-19.30	covid-19.30	PROPN
hls-10800	42	148	therefore	therefore	ADV
hls-10800	42	149	,	,	PUNCT
hls-10800	42	150	covid-19	covid-19	PROPN
hls-10800	42	151	can	can	AUX
hls-10800	42	152	affect	affect	VERB
hls-10800	42	153	the	the	DET
hls-10800	42	154	brain	brain	NOUN
hls-10800	42	155	and	and	CCONJ
hls-10800	42	156	leads	lead	VERB
hls-10800	42	157	to	to	ADP
hls-10800	42	158	neurocognitive	neurocognitive	ADJ
hls-10800	42	159	impairments	impairment	NOUN
hls-10800	42	160	.	.	PUNCT
hls-10800	43	1	conclusions	conclusion	NOUN
hls-10800	43	2	according	accord	VERB
hls-10800	43	3	to	to	ADP
hls-10800	43	4	the	the	DET
hls-10800	43	5	fact	fact	NOUN
hls-10800	43	6	that	that	SCONJ
hls-10800	43	7	receptors	receptor	NOUN
hls-10800	43	8	,	,	PUNCT
hls-10800	43	9	which	which	PRON
hls-10800	43	10	are	be	AUX
hls-10800	43	11	for	for	ADP
hls-10800	43	12	virus	virus	NOUN
hls-10800	43	13	entry	entry	NOUN
hls-10800	43	14	,	,	PUNCT
hls-10800	43	15	exist	exist	VERB
hls-10800	43	16	on	on	ADP
hls-10800	43	17	many	many	ADJ
hls-10800	43	18	tissues	tissue	NOUN
hls-10800	43	19	such	such	ADJ
hls-10800	43	20	as	as	ADP
hls-10800	43	21	the	the	DET
hls-10800	43	22	cns	cns	NOUN
hls-10800	43	23	,	,	PUNCT
hls-10800	43	24	the	the	DET
hls-10800	43	25	adverse	adverse	ADJ
hls-10800	43	26	effects	effect	NOUN
hls-10800	43	27	of	of	ADP
hls-10800	43	28	the	the	DET
hls-10800	43	29	virus	virus	NOUN
hls-10800	43	30	will	will	AUX
hls-10800	43	31	not	not	PART
hls-10800	43	32	be	be	AUX
hls-10800	43	33	limited	limit	VERB
hls-10800	43	34	to	to	ADP
hls-10800	43	35	the	the	DET
hls-10800	43	36	lungs	lung	NOUN
hls-10800	43	37	.	.	PUNCT
hls-10800	44	1	as	as	SCONJ
hls-10800	44	2	the	the	DET
hls-10800	44	3	studies	study	NOUN
hls-10800	44	4	showed	show	VERB
hls-10800	44	5	,	,	PUNCT
hls-10800	44	6	viruses	virus	NOUN
hls-10800	44	7	,	,	PUNCT
hls-10800	44	8	via	via	ADP
hls-10800	44	9	altering	alter	VERB
hls-10800	44	10	blood	blood	NOUN
hls-10800	44	11	brain	brain	NOUN
hls-10800	44	12	barrier	barrier	NOUN
hls-10800	44	13	(	(	PUNCT
hls-10800	44	14	bbb	bbb	NOUN
hls-10800	44	15	)	)	PUNCT
hls-10800	44	16	permeability	permeability	NOUN
hls-10800	44	17	access	access	NOUN
hls-10800	44	18	to	to	ADP
hls-10800	44	19	the	the	DET
hls-10800	44	20	cns	cns	NOUN
hls-10800	44	21	and	and	CCONJ
hls-10800	44	22	leads	lead	VERB
hls-10800	44	23	to	to	ADP
hls-10800	44	24	different	different	ADJ
hls-10800	44	25	neuronal	neuronal	ADJ
hls-10800	44	26	injuries	injury	NOUN
hls-10800	44	27	.	.	PUNCT
hls-10800	45	1	evidence	evidence	NOUN
hls-10800	45	2	suggests	suggest	VERB
hls-10800	45	3	that	that	SCONJ
hls-10800	45	4	inflammatory	inflammatory	ADJ
hls-10800	45	5	pathways	pathway	NOUN
hls-10800	45	6	and	and	CCONJ
hls-10800	45	7	cytokine	cytokine	VERB
hls-10800	45	8	storms	storm	NOUN
hls-10800	45	9	induce	induce	VERB
hls-10800	45	10	neuronal	neuronal	ADJ
hls-10800	45	11	damage	damage	NOUN
hls-10800	45	12	.	.	PUNCT
hls-10800	46	1	effects	effect	NOUN
hls-10800	46	2	of	of	ADP
hls-10800	46	3	cytokine	cytokine	ADJ
hls-10800	46	4	storms	storm	NOUN
hls-10800	46	5	are	be	AUX
hls-10800	46	6	documented	document	VERB
hls-10800	46	7	in	in	ADP
hls-10800	46	8	some	some	DET
hls-10800	46	9	neurodegenerative	neurodegenerative	ADJ
hls-10800	46	10	diseases	disease	NOUN
hls-10800	46	11	and	and	CCONJ
hls-10800	46	12	neuropsychiatric	neuropsychiatric	ADJ
hls-10800	46	13	complications	complication	NOUN
hls-10800	46	14	.	.	PUNCT
hls-10800	47	1	in	in	ADP
hls-10800	47	2	addition	addition	NOUN
hls-10800	47	3	,	,	PUNCT
hls-10800	47	4	clinical	clinical	ADJ
hls-10800	47	5	findings	finding	NOUN
hls-10800	47	6	in	in	ADP
hls-10800	47	7	covid-19	covid-19	PROPN
hls-10800	47	8	patients	patient	NOUN
hls-10800	47	9	showed	show	VERB
hls-10800	47	10	not	not	PART
hls-10800	47	11	only	only	ADV
hls-10800	47	12	pulmonary	pulmonary	ADJ
hls-10800	47	13	problems	problem	NOUN
hls-10800	47	14	but	but	CCONJ
hls-10800	47	15	also	also	ADV
hls-10800	47	16	neuronal	neuronal	ADJ
hls-10800	47	17	complications	complication	NOUN
hls-10800	47	18	such	such	ADJ
hls-10800	47	19	as	as	ADP
hls-10800	47	20	epilepsy	epilepsy	NOUN
hls-10800	47	21	,	,	PUNCT
hls-10800	47	22	intracranial	intracranial	ADJ
hls-10800	47	23	infections	infection	NOUN
hls-10800	47	24	,	,	PUNCT
hls-10800	47	25	encephalitis	encephalitis	NOUN
hls-10800	47	26	,	,	PUNCT
hls-10800	47	27	meningitis	meningitis	NOUN
hls-10800	47	28	,	,	PUNCT
hls-10800	47	29	dizziness	dizziness	NOUN
hls-10800	47	30	,	,	PUNCT
hls-10800	47	31	depression	depression	NOUN
hls-10800	47	32	,	,	PUNCT
hls-10800	47	33	parkinsonism	parkinsonism	NOUN
hls-10800	47	34	,	,	PUNCT
hls-10800	47	35	confusion	confusion	NOUN
hls-10800	47	36	,	,	PUNCT
hls-10800	47	37	headache	headache	NOUN
hls-10800	47	38	,	,	PUNCT
hls-10800	47	39	insomnia	insomnia	NOUN
hls-10800	47	40	,	,	PUNCT
hls-10800	47	41	stroke	stroke	NOUN
hls-10800	47	42	,	,	PUNCT
hls-10800	47	43	myelitis	myelitis	NOUN
hls-10800	47	44	,	,	PUNCT
hls-10800	47	45	etc	etc	X
hls-10800	47	46	.	.	X
hls-10800	48	1	although	although	SCONJ
hls-10800	48	2	these	these	DET
hls-10800	48	3	documents	document	NOUN
hls-10800	48	4	are	be	AUX
hls-10800	48	5	at	at	ADP
hls-10800	48	6	preliminary	preliminary	ADJ
hls-10800	48	7	stages	stage	NOUN
hls-10800	48	8	and	and	CCONJ
hls-10800	48	9	we	we	PRON
hls-10800	48	10	need	need	VERB
hls-10800	48	11	more	more	ADJ
hls-10800	48	12	information	information	NOUN
hls-10800	48	13	about	about	ADP
hls-10800	48	14	the	the	DET
hls-10800	48	15	virus	virus	NOUN
hls-10800	48	16	,	,	PUNCT
hls-10800	48	17	special	special	ADJ
hls-10800	48	18	attention	attention	NOUN
hls-10800	48	19	must	must	AUX
hls-10800	48	20	be	be	AUX
hls-10800	48	21	given	give	VERB
hls-10800	48	22	to	to	ADP
hls-10800	48	23	patients	patient	NOUN
hls-10800	48	24	with	with	ADP
hls-10800	48	25	covid-19	covid-19	PROPN
hls-10800	48	26	for	for	ADP
hls-10800	48	27	preventing	prevent	VERB
hls-10800	48	28	neurological	neurological	ADJ
hls-10800	48	29	damage	damage	NOUN
hls-10800	48	30	in	in	ADP
hls-10800	48	31	the	the	DET
hls-10800	48	32	future	future	NOUN
hls-10800	48	33	until	until	SCONJ
hls-10800	48	34	a	a	DET
hls-10800	48	35	specific	specific	ADJ
hls-10800	48	36	treatment	treatment	NOUN
hls-10800	48	37	is	be	AUX
hls-10800	48	38	available	available	ADJ
hls-10800	48	39	.	.	PUNCT
hls-10800	49	1	references	reference	NOUN
hls-10800	49	2	1	1	NUM
hls-10800	49	3	.	.	PUNCT
hls-10800	50	1	chaplin	chaplin	PROPN
hls-10800	50	2	s.	s.	PROPN
hls-10800	50	3	covid-19	covid-19	PROPN
hls-10800	50	4	:	:	PUNCT
hls-10800	50	5	a	a	DET
hls-10800	50	6	brief	brief	ADJ
hls-10800	50	7	history	history	NOUN
hls-10800	50	8	and	and	CCONJ
hls-10800	50	9	treatments	treatment	NOUN
hls-10800	50	10	in	in	ADP
hls-10800	50	11	development	development	NOUN
hls-10800	50	12	.	.	PUNCT
hls-10800	51	1	prescriber	prescriber	NOUN
hls-10800	51	2	2020;31:23	2020;31:23	NUM
hls-10800	51	3	-	-	SYM
hls-10800	51	4	8	8	NUM
hls-10800	51	5	.	.	NOUN
hls-10800	51	6	2	2	NUM
hls-10800	51	7	.	.	X
hls-10800	51	8	zhu	zhu	PROPN
hls-10800	51	9	n	n	CCONJ
hls-10800	51	10	,	,	PUNCT
hls-10800	51	11	zhang	zhang	PROPN
hls-10800	51	12	d	d	PROPN
hls-10800	51	13	,	,	PUNCT
hls-10800	51	14	wang	wang	PROPN
hls-10800	51	15	w	w	PROPN
hls-10800	51	16	,	,	PUNCT
hls-10800	51	17	et	et	PROPN
hls-10800	51	18	al	al	PROPN
hls-10800	51	19	.	.	PUNCT
hls-10800	52	1	a	a	DET
hls-10800	52	2	novel	novel	ADJ
hls-10800	52	3	coronavirus	coronavirus	NOUN
hls-10800	52	4	from	from	ADP
hls-10800	52	5	patients	patient	NOUN
hls-10800	52	6	with	with	ADP
hls-10800	52	7	pneumonia	pneumonia	NOUN
hls-10800	52	8	in	in	ADP
hls-10800	52	9	china	china	PROPN
hls-10800	52	10	,	,	PUNCT
hls-10800	52	11	2019	2019	NUM
hls-10800	52	12	.	.	PUNCT
hls-10800	53	1	n	n	X
hls-10800	53	2	engl	engl	PROPN
hls-10800	53	3	j	j	PROPN
hls-10800	53	4	med	me	VERB
hls-10800	53	5	2020;382:727	2020;382:727	NUM
hls-10800	53	6	-	-	SYM
hls-10800	53	7	33	33	NUM
hls-10800	53	8	.	.	PUNCT
hls-10800	54	1	3	3	X
hls-10800	54	2	.	.	X
hls-10800	55	1	deng	deng	PROPN
hls-10800	55	2	s	s	PROPN
hls-10800	55	3	-	-	PROPN
hls-10800	55	4	q	q	NOUN
hls-10800	55	5	,	,	PUNCT
hls-10800	55	6	peng	peng	PROPN
hls-10800	55	7	h	h	PROPN
hls-10800	55	8	-	-	PUNCT
hls-10800	55	9	j.	j.	PROPN
hls-10800	55	10	characteristics	characteristics	PROPN
hls-10800	55	11	of	of	ADP
hls-10800	55	12	and	and	CCONJ
hls-10800	55	13	public	public	ADJ
hls-10800	55	14	health	health	NOUN
hls-10800	55	15	responses	response	NOUN
hls-10800	55	16	to	to	ADP
hls-10800	55	17	the	the	DET
hls-10800	55	18	coronavirus	coronavirus	NOUN
hls-10800	55	19	disease	disease	NOUN
hls-10800	55	20	2019	2019	NUM
hls-10800	55	21	outbreak	outbreak	NOUN
hls-10800	55	22	in	in	ADP
hls-10800	55	23	china	china	PROPN
hls-10800	55	24	.	.	PUNCT
hls-10800	56	1	j	j	PROPN
hls-10800	56	2	clin	clin	PROPN
hls-10800	56	3	med	med	PROPN
hls-10800	56	4	2020;9:575	2020;9:575	NUM
hls-10800	56	5	.	.	PUNCT
hls-10800	57	1	4	4	NUM
hls-10800	57	2	.	.	X
hls-10800	57	3	hassan	hassan	PROPN
hls-10800	57	4	sa	sa	PROPN
hls-10800	57	5	,	,	PUNCT
hls-10800	57	6	sheikh	sheikh	PROPN
hls-10800	57	7	fn	fn	PROPN
hls-10800	57	8	,	,	PUNCT
hls-10800	57	9	jamal	jamal	PROPN
hls-10800	57	10	s	s	PROPN
hls-10800	57	11	,	,	PUNCT
hls-10800	57	12	et	et	PROPN
hls-10800	57	13	al	al	PROPN
hls-10800	57	14	.	.	PROPN
hls-10800	57	15	coronavirus	coronavirus	PROPN
hls-10800	57	16	(	(	PUNCT
hls-10800	57	17	covid-19	covid-19	PROPN
hls-10800	57	18	):	):	PUNCT
hls-10800	57	19	a	a	DET
hls-10800	57	20	review	review	NOUN
hls-10800	57	21	of	of	ADP
hls-10800	57	22	clinical	clinical	ADJ
hls-10800	57	23	features	feature	NOUN
hls-10800	57	24	,	,	PUNCT
hls-10800	57	25	diagnosis	diagnosis	NOUN
hls-10800	57	26	,	,	PUNCT
hls-10800	57	27	and	and	CCONJ
hls-10800	57	28	treatment	treatment	NOUN
hls-10800	57	29	.	.	PUNCT
hls-10800	58	1	cureus	cureus	PROPN
hls-10800	58	2	2020;12	2020;12	NUM
hls-10800	58	3	:	:	PUNCT
hls-10800	58	4	e7355	e7355	NOUN
hls-10800	58	5	.	.	PUNCT
hls-10800	59	1	5	5	NUM
hls-10800	59	2	.	.	PUNCT
hls-10800	59	3	kanwar	kanwar	PROPN
hls-10800	59	4	d	d	PROPN
hls-10800	59	5	,	,	PUNCT
hls-10800	59	6	imran	imran	PROPN
hls-10800	59	7	m	m	PROPN
hls-10800	59	8	,	,	PUNCT
hls-10800	59	9	wasay	wasay	VERB
hls-10800	59	10	m.	m.	NOUN
hls-10800	59	11	neurological	neurological	ADJ
hls-10800	59	12	involvement	involvement	NOUN
hls-10800	59	13	in	in	ADP
hls-10800	59	14	coid-19	coid-19	PROPN
hls-10800	59	15	infections	infection	NOUN
hls-10800	59	16	;	;	PUNCT
hls-10800	59	17	pathophysiology	pathophysiology	NOUN
hls-10800	59	18	,	,	PUNCT
hls-10800	59	19	presentation	presentation	NOUN
hls-10800	59	20	and	and	CCONJ
hls-10800	59	21	outcome	outcome	NOUN
hls-10800	59	22	.	.	PUNCT
hls-10800	60	1	pakistan	pakistan	PROPN
hls-10800	60	2	j	j	PROPN
hls-10800	60	3	neurol	neurol	PROPN
hls-10800	60	4	sci	sci	PROPN
hls-10800	60	5	2020;15:52	2020;15:52	NUM
hls-10800	60	6	-	-	SYM
hls-10800	60	7	8	8	NUM
hls-10800	60	8	.	.	NOUN
hls-10800	60	9	6	6	NUM
hls-10800	60	10	.	.	X
hls-10800	60	11	carod	carod	NOUN
hls-10800	60	12	-	-	PUNCT
hls-10800	60	13	artal	artal	PROPN
hls-10800	60	14	fj	fj	PROPN
hls-10800	60	15	.	.	PROPN
hls-10800	60	16	neurological	neurological	ADJ
hls-10800	60	17	complications	complication	NOUN
hls-10800	60	18	of	of	ADP
hls-10800	60	19	coronavirus	coronavirus	NOUN
hls-10800	60	20	and	and	CCONJ
hls-10800	60	21	covid-19	covid-19	PROPN
hls-10800	60	22	.	.	PROPN
hls-10800	60	23	revista	revista	PROPN
hls-10800	60	24	de	de	PROPN
hls-10800	60	25	neurologia	neurologia	X
hls-10800	60	26	2020;70:311	2020;70:311	NOUN
hls-10800	60	27	-	-	SYM
hls-10800	60	28	22	22	NUM
hls-10800	60	29	.	.	PUNCT
hls-10800	61	1	7	7	X
hls-10800	61	2	.	.	X
hls-10800	61	3	zhou	zhou	PROPN
hls-10800	61	4	y	y	PROPN
hls-10800	61	5	,	,	PUNCT
hls-10800	61	6	li	li	PROPN
hls-10800	61	7	w	w	PROPN
hls-10800	61	8	,	,	PUNCT
hls-10800	61	9	wang	wang	PROPN
hls-10800	61	10	d	d	PROPN
hls-10800	61	11	,	,	PUNCT
hls-10800	61	12	et	et	PROPN
hls-10800	61	13	al	al	PROPN
hls-10800	61	14	.	.	PROPN
hls-10800	62	1	clinical	clinical	ADJ
hls-10800	62	2	time	time	NOUN
hls-10800	62	3	course	course	NOUN
hls-10800	62	4	of	of	ADP
hls-10800	62	5	covid-19	covid-19	PROPN
hls-10800	62	6	,	,	PUNCT
hls-10800	62	7	its	its	PRON
hls-10800	62	8	neurological	neurological	ADJ
hls-10800	62	9	manifestation	manifestation	NOUN
hls-10800	62	10	and	and	CCONJ
hls-10800	62	11	some	some	DET
hls-10800	62	12	thoughts	thought	NOUN
hls-10800	62	13	on	on	ADP
hls-10800	62	14	its	its	PRON
hls-10800	62	15	management	management	NOUN
hls-10800	62	16	.	.	PUNCT
hls-10800	63	1	stroke	stroke	PROPN
hls-10800	63	2	vasc	vasc	ADP
hls-10800	63	3	neurol	neurol	PROPN
hls-10800	63	4	2020;5:177	2020;5:177	NUM
hls-10800	63	5	-	-	SYM
hls-10800	63	6	179	179	NUM
hls-10800	63	7	.	.	NOUN
hls-10800	63	8	8	8	NUM
hls-10800	63	9	.	.	PUNCT
hls-10800	63	10	ellul	ellul	PROPN
hls-10800	63	11	ma	ma	PROPN
hls-10800	63	12	,	,	PUNCT
hls-10800	63	13	benjamin	benjamin	PROPN
hls-10800	63	14	l	l	PROPN
hls-10800	63	15	,	,	PUNCT
hls-10800	63	16	singh	singh	PROPN
hls-10800	63	17	b	b	PROPN
hls-10800	63	18	,	,	PUNCT
hls-10800	63	19	et	et	PROPN
hls-10800	63	20	al	al	PROPN
hls-10800	63	21	.	.	PROPN
hls-10800	64	1	neurological	neurological	ADJ
hls-10800	64	2	associations	association	NOUN
hls-10800	64	3	of	of	ADP
hls-10800	64	4	covid19	covid19	NOUN
hls-10800	64	5	.	.	PUNCT
hls-10800	65	1	lancet	lancet	PROPN
hls-10800	65	2	neurol	neurol	PROPN
hls-10800	65	3	2020;19:767	2020;19:767	NOUN
hls-10800	65	4	-	-	SYM
hls-10800	65	5	783	783	NUM
hls-10800	65	6	.	.	PUNCT
hls-10800	66	1	9	9	NUM
hls-10800	66	2	.	.	PUNCT
hls-10800	67	1	baker	baker	PROPN
hls-10800	67	2	d	d	PROPN
hls-10800	67	3	,	,	PUNCT
hls-10800	67	4	amor	amor	PROPN
hls-10800	67	5	s	s	PROPN
hls-10800	67	6	,	,	PUNCT
hls-10800	67	7	kang	kang	PROPN
hls-10800	67	8	as	as	ADP
hls-10800	67	9	,	,	PUNCT
hls-10800	67	10	et	et	PROPN
hls-10800	67	11	al	al	PROPN
hls-10800	67	12	.	.	PUNCT
hls-10800	68	1	the	the	DET
hls-10800	68	2	underpinning	underpinning	ADJ
hls-10800	68	3	biology	biology	NOUN
hls-10800	68	4	relating	relate	VERB
hls-10800	68	5	to	to	ADP
hls-10800	68	6	multiple	multiple	ADJ
hls-10800	68	7	sclerosis	sclerosis	NOUN
hls-10800	68	8	disease	disease	NOUN
hls-10800	68	9	modifying	modify	VERB
hls-10800	68	10	treatments	treatment	NOUN
hls-10800	68	11	during	during	ADP
hls-10800	68	12	the	the	DET
hls-10800	68	13	covid-19	covid-19	PROPN
hls-10800	68	14	pandemic	pandemic	NOUN
hls-10800	68	15	.	.	PUNCT
hls-10800	69	1	mult	mult	PROPN
hls-10800	69	2	scler	scler	PROPN
hls-10800	69	3	relat	relat	PROPN
hls-10800	69	4	disord	disord	PROPN
hls-10800	69	5	2020;43:102174	2020;43:102174	NUM
hls-10800	69	6	.	.	PROPN
hls-10800	69	7	10	10	NUM
hls-10800	69	8	.	.	PUNCT
hls-10800	70	1	venkatesan	venkatesan	PROPN
hls-10800	70	2	a	a	PRON
hls-10800	70	3	,	,	PUNCT
hls-10800	70	4	tunkel	tunkel	PROPN
hls-10800	70	5	ar	ar	PROPN
hls-10800	70	6	,	,	PUNCT
hls-10800	70	7	bloch	bloch	PROPN
hls-10800	70	8	kc	kc	PROPN
hls-10800	70	9	,	,	PUNCT
hls-10800	70	10	et	et	PROPN
hls-10800	70	11	al	al	PROPN
hls-10800	70	12	.	.	PUNCT
hls-10800	70	13	case	case	NOUN
hls-10800	70	14	definitions	definition	NOUN
hls-10800	70	15	,	,	PUNCT
hls-10800	70	16	diagnostic	diagnostic	ADJ
hls-10800	70	17	algorithms	algorithm	NOUN
hls-10800	70	18	,	,	PUNCT
hls-10800	70	19	and	and	CCONJ
hls-10800	70	20	priorities	priority	NOUN
hls-10800	70	21	in	in	ADP
hls-10800	70	22	encephalitis	encephalitis	NOUN
hls-10800	70	23	:	:	PUNCT
hls-10800	70	24	consensus	consensus	NOUN
hls-10800	70	25	statement	statement	NOUN
hls-10800	70	26	of	of	ADP
hls-10800	70	27	the	the	DET
hls-10800	70	28	international	international	ADJ
hls-10800	70	29	encephalitis	encephalitis	ADJ
hls-10800	70	30	consortium	consortium	NOUN
hls-10800	70	31	.	.	PUNCT
hls-10800	71	1	clin	clin	PROPN
hls-10800	71	2	infect	infect	VERB
hls-10800	71	3	di	di	PROPN
hls-10800	71	4	2013;57:1114	2013;57:1114	NUM
hls-10800	71	5	-	-	SYM
hls-10800	71	6	28	28	NUM
hls-10800	71	7	.	.	PUNCT
hls-10800	72	1	11	11	NUM
hls-10800	72	2	.	.	X
hls-10800	72	3	fehr	fehr	PROPN
hls-10800	72	4	ar	ar	PROPN
hls-10800	72	5	,	,	PUNCT
hls-10800	72	6	perlman	perlman	PROPN
hls-10800	72	7	s.	s.	PROPN
hls-10800	72	8	coronaviruses	coronaviruse	NOUN
hls-10800	72	9	:	:	PUNCT
hls-10800	72	10	an	an	DET
hls-10800	72	11	overview	overview	NOUN
hls-10800	72	12	of	of	ADP
hls-10800	72	13	their	their	PRON
hls-10800	72	14	replication	replication	NOUN
hls-10800	72	15	and	and	CCONJ
hls-10800	72	16	pathogenesis	pathogenesis	NOUN
hls-10800	72	17	.	.	PUNCT
hls-10800	73	1	methods	method	NOUN
hls-10800	73	2	mol	mol	ADP
hls-10800	73	3	biol	biol	PROPN
hls-10800	73	4	2015	2015	NUM
hls-10800	73	5	;	;	PUNCT
hls-10800	73	6	1282:1	1282:1	NUM
hls-10800	73	7	-	-	SYM
hls-10800	73	8	23	23	NUM
hls-10800	73	9	.	.	PUNCT
hls-10800	73	10	12	12	NUM
hls-10800	73	11	.	.	PUNCT
hls-10800	74	1	lima	lima	PROPN
hls-10800	74	2	m	m	PROPN
hls-10800	74	3	,	,	PUNCT
hls-10800	74	4	siokas	siokas	ADJ
hls-10800	74	5	v	v	NOUN
hls-10800	74	6	,	,	PUNCT
hls-10800	74	7	aloizou	aloizou	VERB
hls-10800	74	8	a	a	DET
hls-10800	74	9	-	-	PUNCT
hls-10800	74	10	m	m	NOUN
hls-10800	74	11	,	,	PUNCT
hls-10800	74	12	et	et	PROPN
hls-10800	74	13	al	al	PROPN
hls-10800	74	14	.	.	PUNCT
hls-10800	75	1	unraveling	unravel	VERB
hls-10800	75	2	the	the	DET
hls-10800	75	3	possible	possible	ADJ
hls-10800	75	4	routes	route	NOUN
hls-10800	75	5	of	of	ADP
hls-10800	75	6	sars	sar	NOUN
hls-10800	75	7	-	-	PUNCT
hls-10800	75	8	cov-2	cov-2	PART
hls-10800	75	9	invasion	invasion	NOUN
hls-10800	75	10	into	into	ADP
hls-10800	75	11	the	the	DET
hls-10800	75	12	central	central	ADJ
hls-10800	75	13	nervous	nervous	ADJ
hls-10800	75	14	system	system	NOUN
hls-10800	75	15	.	.	PUNCT
hls-10800	76	1	curr	curr	PROPN
hls-10800	76	2	treat	treat	NOUN
hls-10800	76	3	options	option	NOUN
hls-10800	76	4	neurol	neurol	NOUN
hls-10800	76	5	2020;22:37	2020;22:37	NUM
hls-10800	76	6	13	13	NUM
hls-10800	76	7	.	.	PUNCT
hls-10800	77	1	dewanjee	dewanjee	PROPN
hls-10800	77	2	s	s	PROPN
hls-10800	77	3	,	,	PUNCT
hls-10800	77	4	vallamkondu	vallamkondu	PROPN
hls-10800	77	5	j	j	PROPN
hls-10800	77	6	,	,	PUNCT
hls-10800	77	7	kalra	kalra	ADJ
hls-10800	77	8	rs	rs	NOUN
hls-10800	77	9	,	,	PUNCT
hls-10800	77	10	et	et	PROPN
hls-10800	77	11	al	al	PROPN
hls-10800	77	12	.	.	PUNCT
hls-10800	78	1	emerging	emerge	VERB
hls-10800	78	2	covid-19	covid-19	PROPN
hls-10800	78	3	neurological	neurological	ADJ
hls-10800	78	4	manifestations	manifestation	NOUN
hls-10800	78	5	:	:	PUNCT
hls-10800	78	6	present	present	ADJ
hls-10800	78	7	outlook	outlook	NOUN
hls-10800	78	8	and	and	CCONJ
hls-10800	78	9	potential	potential	ADJ
hls-10800	78	10	neurological	neurological	ADJ
hls-10800	78	11	challenges	challenge	NOUN
hls-10800	78	12	in	in	ADP
hls-10800	78	13	covid-19	covid-19	PROPN
hls-10800	78	14	pandemic	pandemic	NOUN
hls-10800	78	15	.	.	PUNCT
hls-10800	79	1	mol	mol	ADP
hls-10800	79	2	neurobiol	neurobiol	NOUN
hls-10800	79	3	2021;58:4694	2021;58:4694	NUM
hls-10800	79	4	-	-	SYM
hls-10800	79	5	4715	4715	NUM
hls-10800	79	6	.	.	PUNCT
hls-10800	80	1	14	14	NUM
hls-10800	80	2	.	.	PUNCT
hls-10800	81	1	li	li	PROPN
hls-10800	81	2	yc	yc	PROPN
hls-10800	81	3	,	,	PUNCT
hls-10800	81	4	bai	bai	PROPN
hls-10800	81	5	wz	wz	PROPN
hls-10800	81	6	,	,	PUNCT
hls-10800	81	7	hashikawa	hashikawa	PROPN
hls-10800	81	8	t.	t.	PROPN
hls-10800	81	9	the	the	DET
hls-10800	81	10	neuroinvasive	neuroinvasive	ADJ
hls-10800	81	11	potential	potential	NOUN
hls-10800	81	12	of	of	ADP
hls-10800	81	13	sars	sars	PROPN
hls-10800	81	14	�	�	PROPN
hls-10800	81	15	cov2	cov2	PROPN
hls-10800	81	16	may	may	AUX
hls-10800	81	17	play	play	VERB
hls-10800	81	18	a	a	DET
hls-10800	81	19	role	role	NOUN
hls-10800	81	20	in	in	ADP
hls-10800	81	21	the	the	DET
hls-10800	81	22	respiratory	respiratory	ADJ
hls-10800	81	23	failure	failure	NOUN
hls-10800	81	24	of	of	ADP
hls-10800	81	25	covid-19	covid-19	PROPN
hls-10800	81	26	patients	patient	NOUN
hls-10800	81	27	.	.	PUNCT
hls-10800	82	1	j	j	PROPN
hls-10800	82	2	med	med	PROPN
hls-10800	82	3	virol	virol	NOUN
hls-10800	82	4	2020;92:552	2020;92:552	NUM
hls-10800	82	5	-	-	SYM
hls-10800	82	6	5	5	NUM
hls-10800	82	7	.	.	NOUN
hls-10800	82	8	15	15	NUM
hls-10800	82	9	.	.	PUNCT
hls-10800	83	1	bilinska	bilinska	PROPN
hls-10800	83	2	k	k	PROPN
hls-10800	83	3	,	,	PUNCT
hls-10800	83	4	jakubowska	jakubowska	PROPN
hls-10800	83	5	p	p	PROPN
hls-10800	83	6	,	,	PUNCT
hls-10800	83	7	von	von	PROPN
hls-10800	83	8	bartheld	bartheld	PROPN
hls-10800	83	9	cs	cs	PROPN
hls-10800	83	10	,	,	PUNCT
hls-10800	83	11	butowt	butowt	NOUN
hls-10800	83	12	r.	r.	NOUN
hls-10800	83	13	expression	expression	NOUN
hls-10800	83	14	of	of	ADP
hls-10800	83	15	the	the	DET
hls-10800	83	16	sars	sar	NOUN
hls-10800	83	17	-	-	PUNCT
hls-10800	83	18	cov-2	cov-2	NOUN
hls-10800	83	19	entry	entry	NOUN
hls-10800	83	20	proteins	protein	NOUN
hls-10800	83	21	,	,	PUNCT
hls-10800	83	22	ace2	ace2	NOUN
hls-10800	83	23	and	and	CCONJ
hls-10800	83	24	tmprss2	tmprss2	ADP
hls-10800	83	25	,	,	PUNCT
hls-10800	83	26	in	in	ADP
hls-10800	83	27	cells	cell	NOUN
hls-10800	83	28	of	of	ADP
hls-10800	83	29	the	the	DET
hls-10800	83	30	olfactory	olfactory	ADJ
hls-10800	83	31	epithelium	epithelium	NOUN
hls-10800	83	32	:	:	PUNCT
hls-10800	83	33	identification	identification	NOUN
hls-10800	83	34	of	of	ADP
hls-10800	83	35	cell	cell	NOUN
hls-10800	83	36	types	type	NOUN
hls-10800	83	37	and	and	CCONJ
hls-10800	83	38	trends	trend	NOUN
hls-10800	83	39	with	with	ADP
hls-10800	83	40	age	age	NOUN
hls-10800	83	41	.	.	PUNCT
hls-10800	84	1	acs	acs	PROPN
hls-10800	84	2	chem	chem	NOUN
hls-10800	84	3	neurosci	neurosci	VERB
hls-10800	84	4	2020;11:1555	2020;11:1555	NUM
hls-10800	84	5	-	-	SYM
hls-10800	84	6	62	62	NUM
hls-10800	84	7	.	.	PUNCT
hls-10800	85	1	16	16	NUM
hls-10800	85	2	.	.	PUNCT
hls-10800	86	1	yavarpour	yavarpour	PROPN
hls-10800	86	2	-	-	PUNCT
hls-10800	86	3	bali	bali	PROPN
hls-10800	86	4	h	h	PROPN
hls-10800	86	5	,	,	PUNCT
hls-10800	86	6	ghasemi	ghasemi	NOUN
hls-10800	86	7	-	-	PUNCT
hls-10800	86	8	kasman	kasman	NOUN
hls-10800	86	9	m.	m.	NOUN
hls-10800	86	10	update	update	NOUN
hls-10800	86	11	on	on	ADP
hls-10800	86	12	neurological	neurological	ADJ
hls-10800	86	13	manifestations	manifestation	NOUN
hls-10800	86	14	of	of	ADP
hls-10800	86	15	covid-19	covid-19	PROPN
hls-10800	86	16	.	.	PUNCT
hls-10800	87	1	life	life	NOUN
hls-10800	87	2	sci	sci	PROPN
hls-10800	87	3	2020;257:118063	2020;257:118063	NUM
hls-10800	87	4	.	.	PUNCT
hls-10800	87	5	17	17	NUM
hls-10800	87	6	.	.	PUNCT
hls-10800	88	1	iadecola	iadecola	PROPN
hls-10800	88	2	c	c	NOUN
hls-10800	88	3	,	,	PUNCT
hls-10800	88	4	anrather	anrather	PROPN
hls-10800	88	5	j	j	PROPN
hls-10800	88	6	,	,	PUNCT
hls-10800	88	7	kamel	kamel	PROPN
hls-10800	88	8	h.	h.	PROPN
hls-10800	88	9	effects	effect	NOUN
hls-10800	88	10	of	of	ADP
hls-10800	88	11	covid-19	covid-19	PROPN
hls-10800	88	12	on	on	ADP
hls-10800	88	13	the	the	DET
hls-10800	88	14	nervous	nervous	ADJ
hls-10800	88	15	system	system	NOUN
hls-10800	88	16	.	.	PUNCT
hls-10800	89	1	cell	cell	NOUN
hls-10800	89	2	.	.	PUNCT
hls-10800	90	1	2020;183:16	2020;183:16	NUM
hls-10800	90	2	-	-	SYM
hls-10800	90	3	27.e1	27.e1	PROPN
hls-10800	90	4	.	.	PROPN
hls-10800	90	5	18	18	NUM
hls-10800	90	6	.	.	PUNCT
hls-10800	91	1	lodigiani	lodigiani	PROPN
hls-10800	91	2	c	c	PROPN
hls-10800	91	3	,	,	PUNCT
hls-10800	91	4	iapichino	iapichino	PROPN
hls-10800	91	5	g	g	PROPN
hls-10800	91	6	,	,	PUNCT
hls-10800	91	7	carenzo	carenzo	PROPN
hls-10800	91	8	l	l	PROPN
hls-10800	91	9	,	,	PUNCT
hls-10800	91	10	et	et	PROPN
hls-10800	91	11	al	al	PROPN
hls-10800	91	12	.	.	PROPN
hls-10800	92	1	venous	venous	ADJ
hls-10800	92	2	and	and	CCONJ
hls-10800	92	3	arterial	arterial	ADJ
hls-10800	92	4	thromboembolic	thromboembolic	ADJ
hls-10800	92	5	complications	complication	NOUN
hls-10800	92	6	in	in	ADP
hls-10800	92	7	covid-19	covid-19	PROPN
hls-10800	92	8	patients	patient	NOUN
hls-10800	92	9	admitted	admit	VERB
hls-10800	92	10	to	to	ADP
hls-10800	92	11	an	an	DET
hls-10800	92	12	academic	academic	ADJ
hls-10800	92	13	hospital	hospital	NOUN
hls-10800	92	14	in	in	ADP
hls-10800	92	15	milan	milan	PROPN
hls-10800	92	16	,	,	PUNCT
hls-10800	92	17	italy	italy	PROPN
hls-10800	92	18	.	.	PUNCT
hls-10800	93	1	thromb	thromb	PROPN
hls-10800	93	2	res	re	NOUN
hls-10800	93	3	2020;191:914	2020;191:914	NUM
hls-10800	93	4	.	.	PUNCT
hls-10800	94	1	19	19	NUM
hls-10800	94	2	.	.	PUNCT
hls-10800	95	1	hamming	ham	VERB
hls-10800	95	2	i	i	PRON
hls-10800	95	3	,	,	PUNCT
hls-10800	95	4	timens	timens	PROPN
hls-10800	95	5	w	w	PROPN
hls-10800	95	6	,	,	PUNCT
hls-10800	95	7	bulthuis	bulthuis	PROPN
hls-10800	95	8	m	m	PROPN
hls-10800	95	9	,	,	PUNCT
hls-10800	95	10	et	et	PROPN
hls-10800	95	11	al	al	PROPN
hls-10800	95	12	.	.	PUNCT
hls-10800	95	13	tissue	tissue	NOUN
hls-10800	95	14	distribution	distribution	NOUN
hls-10800	95	15	of	of	ADP
hls-10800	95	16	ace2	ace2	NOUN
hls-10800	95	17	protein	protein	NOUN
hls-10800	95	18	,	,	PUNCT
hls-10800	95	19	the	the	DET
hls-10800	95	20	functional	functional	ADJ
hls-10800	95	21	receptor	receptor	NOUN
hls-10800	95	22	for	for	ADP
hls-10800	95	23	sars	sars	PROPN
hls-10800	95	24	coronavirus	coronavirus	PROPN
hls-10800	95	25	.	.	PUNCT
hls-10800	96	1	a	a	DET
hls-10800	96	2	first	first	ADJ
hls-10800	96	3	step	step	NOUN
hls-10800	96	4	in	in	ADP
hls-10800	96	5	understanding	understand	VERB
hls-10800	96	6	sars	sar	NOUN
hls-10800	96	7	pathogenesis	pathogenesis	NOUN
hls-10800	96	8	.	.	PUNCT
hls-10800	97	1	j	j	PROPN
hls-10800	97	2	pathol	pathol	VERB
hls-10800	97	3	2004;203	2004;203	NUM
hls-10800	97	4	:	:	PUNCT
hls-10800	97	5	631	631	NUM
hls-10800	97	6	-	-	SYM
hls-10800	97	7	7	7	NUM
hls-10800	97	8	.	.	NOUN
hls-10800	97	9	20	20	NUM
hls-10800	97	10	.	.	PUNCT
hls-10800	98	1	abdennour	abdennour	VERB
hls-10800	98	2	l	l	NOUN
hls-10800	98	3	,	,	PUNCT
hls-10800	98	4	zeghal	zeghal	NOUN
hls-10800	98	5	c	c	NOUN
hls-10800	98	6	,	,	PUNCT
hls-10800	98	7	dème	dème	PROPN
hls-10800	98	8	m	m	PROPN
hls-10800	98	9	,	,	PUNCT
hls-10800	98	10	puybasset	puybasset	NOUN
hls-10800	98	11	l	l	NOUN
hls-10800	98	12	,	,	PUNCT
hls-10800	98	13	eds	ed	NOUN
hls-10800	98	14	.	.	PUNCT
hls-10800	98	15	interaction	interaction	NOUN
hls-10800	98	16	cerveaupoumon	cerveaupoumon	NOUN
hls-10800	98	17	.	.	PUNCT
hls-10800	99	1	annales	annale	NOUN
hls-10800	99	2	francaises	francaise	NOUN
hls-10800	99	3	d’anesthesie	d’anesthesie	PROPN
hls-10800	99	4	et	et	PROPN
hls-10800	99	5	de	de	X
hls-10800	99	6	reanimation	reanimation	NOUN
hls-10800	99	7	;	;	PUNCT
hls-10800	99	8	2012	2012	NUM
hls-10800	99	9	:	:	PUNCT
hls-10800	99	10	elsevier	elsevier	NOUN
hls-10800	99	11	.	.	PUNCT
hls-10800	100	1	21	21	NUM
hls-10800	100	2	.	.	PUNCT
hls-10800	101	1	guo	guo	PROPN
hls-10800	101	2	y	y	PROPN
hls-10800	101	3	-	-	PUNCT
hls-10800	101	4	r	r	PROPN
hls-10800	101	5	,	,	PUNCT
hls-10800	101	6	cao	cao	PROPN
hls-10800	101	7	q	q	PROPN
hls-10800	101	8	-	-	PUNCT
hls-10800	101	9	d	d	PROPN
hls-10800	101	10	,	,	PUNCT
hls-10800	101	11	hong	hong	PROPN
hls-10800	101	12	z	z	PROPN
hls-10800	101	13	-	-	PUNCT
hls-10800	101	14	s	s	PROPN
hls-10800	101	15	,	,	PUNCT
hls-10800	101	16	et	et	PROPN
hls-10800	101	17	al	al	PROPN
hls-10800	101	18	.	.	PUNCT
hls-10800	102	1	the	the	DET
hls-10800	102	2	origin	origin	NOUN
hls-10800	102	3	,	,	PUNCT
hls-10800	102	4	transmission	transmission	NOUN
hls-10800	102	5	and	and	CCONJ
hls-10800	102	6	clinical	clinical	ADJ
hls-10800	102	7	therapies	therapy	NOUN
hls-10800	102	8	on	on	ADP
hls-10800	102	9	coronavirus	coronavirus	NOUN
hls-10800	102	10	disease	disease	NOUN
hls-10800	102	11	2019	2019	NUM
hls-10800	102	12	(	(	PUNCT
hls-10800	102	13	covid-19	covid-19	PROPN
hls-10800	102	14	)	)	PUNCT
hls-10800	102	15	outbreak	outbreak	NOUN
hls-10800	102	16	–	–	PUNCT
hls-10800	102	17	an	an	DET
hls-10800	102	18	update	update	NOUN
hls-10800	102	19	on	on	ADP
hls-10800	102	20	the	the	DET
hls-10800	102	21	status	status	NOUN
hls-10800	102	22	.	.	PUNCT
hls-10800	103	1	military	military	ADJ
hls-10800	103	2	med	med	PROPN
hls-10800	103	3	res	re	NOUN
hls-10800	103	4	2020;7:1	2020;7:1	NOUN
hls-10800	103	5	-	-	SYM
hls-10800	103	6	10	10	NUM
hls-10800	103	7	.	.	PUNCT
hls-10800	104	1	22	22	NUM
hls-10800	104	2	.	.	PUNCT
hls-10800	105	1	huang	huang	PROPN
hls-10800	105	2	c	c	PROPN
hls-10800	105	3	,	,	PUNCT
hls-10800	105	4	wang	wang	PROPN
hls-10800	105	5	y	y	PROPN
hls-10800	105	6	,	,	PUNCT
hls-10800	105	7	li	li	PROPN
hls-10800	105	8	x	x	PROPN
hls-10800	105	9	,	,	PUNCT
hls-10800	105	10	ren	ren	PROPN
hls-10800	105	11	l	l	PROPN
hls-10800	105	12	,	,	PUNCT
hls-10800	105	13	zhao	zhao	PROPN
hls-10800	105	14	j	j	PROPN
hls-10800	105	15	,	,	PUNCT
hls-10800	105	16	review	review	VERB
hls-10800	105	17	non	non	ADJ
hls-10800	105	18	-co	-co	PROPN
hls-10800	105	19	mmerc	mmerc	PROPN
hls-10800	105	20	ial	ial	PROPN
hls-10800	106	1	us	us	PROPN
hls-10800	106	2	e	e	NOUN
hls-10800	106	3	o	o	NOUN
hls-10800	107	1	nly	nly	ADV
hls-10800	107	2	[	[	X
hls-10800	107	3	healthcare	healthcare	NOUN
hls-10800	107	4	in	in	ADP
hls-10800	107	5	low	low	ADJ
hls-10800	107	6	-	-	PUNCT
hls-10800	107	7	resource	resource	NOUN
hls-10800	107	8	settings	setting	NOUN
hls-10800	107	9	2022	2022	NUM
hls-10800	107	10	;	;	PUNCT
hls-10800	107	11	10	10	NUM
hls-10800	107	12	:]	:]	X
hls-10800	108	1	[	[	X
hls-10800	108	2	page	page	NOUN
hls-10800	108	3	63	63	NUM
hls-10800	108	4	]	]	PUNCT
hls-10800	108	5	et	et	PROPN
hls-10800	108	6	al	al	PROPN
hls-10800	108	7	.	.	PUNCT
hls-10800	109	1	clinical	clinical	ADJ
hls-10800	109	2	features	feature	NOUN
hls-10800	109	3	of	of	ADP
hls-10800	109	4	patients	patient	NOUN
hls-10800	109	5	infected	infect	VERB
hls-10800	109	6	with	with	ADP
hls-10800	109	7	2019	2019	NUM
hls-10800	109	8	novel	novel	ADJ
hls-10800	109	9	coronavirus	coronavirus	NOUN
hls-10800	109	10	in	in	ADP
hls-10800	109	11	wuhan	wuhan	PROPN
hls-10800	109	12	,	,	PUNCT
hls-10800	109	13	china	china	PROPN
hls-10800	109	14	.	.	PUNCT
hls-10800	110	1	the	the	DET
hls-10800	110	2	lancet	lancet	PROPN
hls-10800	110	3	2020;395:497	2020;395:497	PROPN
hls-10800	110	4	-	-	SYM
hls-10800	110	5	506	506	NUM
hls-10800	110	6	.	.	PUNCT
hls-10800	110	7	23	23	NUM
hls-10800	110	8	.	.	PUNCT
hls-10800	111	1	wang	wang	PROPN
hls-10800	111	2	q	q	PROPN
hls-10800	111	3	,	,	PUNCT
hls-10800	111	4	zhang	zhang	PROPN
hls-10800	111	5	y	y	PROPN
hls-10800	111	6	,	,	PUNCT
hls-10800	111	7	wu	wu	PROPN
hls-10800	111	8	l	l	PROPN
hls-10800	111	9	,	,	PUNCT
hls-10800	111	10	et	et	PROPN
hls-10800	111	11	al	al	PROPN
hls-10800	111	12	.	.	PROPN
hls-10800	112	1	structural	structural	ADJ
hls-10800	112	2	and	and	CCONJ
hls-10800	112	3	functional	functional	ADJ
hls-10800	112	4	basis	basis	NOUN
hls-10800	112	5	of	of	ADP
hls-10800	112	6	sars	sar	NOUN
hls-10800	112	7	-	-	PUNCT
hls-10800	112	8	cov-2	cov-2	NOUN
hls-10800	112	9	entry	entry	NOUN
hls-10800	112	10	by	by	ADP
hls-10800	112	11	using	use	VERB
hls-10800	112	12	human	human	ADJ
hls-10800	112	13	ace2	ace2	NOUN
hls-10800	112	14	.	.	PUNCT
hls-10800	113	1	cell	cell	NOUN
hls-10800	113	2	2020;181:894	2020;181:894	NUM
hls-10800	113	3	-	-	SYM
hls-10800	113	4	904	904	NUM
hls-10800	113	5	.	.	PUNCT
hls-10800	114	1	e9	e9	NUM
hls-10800	114	2	.	.	PROPN
hls-10800	114	3	24	24	NUM
hls-10800	114	4	.	.	PUNCT
hls-10800	115	1	wan	wan	PROPN
hls-10800	115	2	s	s	PROPN
hls-10800	115	3	,	,	PUNCT
hls-10800	115	4	yi	yi	PROPN
hls-10800	115	5	q	q	NOUN
hls-10800	115	6	,	,	PUNCT
hls-10800	115	7	fan	fan	PROPN
hls-10800	115	8	s	s	PROPN
hls-10800	115	9	,	,	PUNCT
hls-10800	115	10	lv	lv	PROPN
hls-10800	115	11	j	j	PROPN
hls-10800	115	12	,	,	PUNCT
hls-10800	115	13	et	et	PROPN
hls-10800	115	14	al	al	PROPN
hls-10800	115	15	.	.	PROPN
hls-10800	116	1	characteristics	characteristic	NOUN
hls-10800	116	2	of	of	ADP
hls-10800	116	3	lymphocyte	lymphocyte	ADJ
hls-10800	116	4	subsets	subset	NOUN
hls-10800	116	5	and	and	CCONJ
hls-10800	116	6	cytokines	cytokine	NOUN
hls-10800	116	7	in	in	ADP
hls-10800	116	8	peripheral	peripheral	ADJ
hls-10800	116	9	blood	blood	NOUN
hls-10800	116	10	of	of	ADP
hls-10800	116	11	123	123	NUM
hls-10800	116	12	hospitalized	hospitalize	VERB
hls-10800	116	13	patients	patient	NOUN
hls-10800	116	14	with	with	ADP
hls-10800	116	15	2019	2019	NUM
hls-10800	116	16	novel	novel	ADJ
hls-10800	116	17	coronavirus	coronavirus	NOUN
hls-10800	116	18	pneumonia	pneumonia	NOUN
hls-10800	116	19	(	(	PUNCT
hls-10800	116	20	ncp	ncp	PROPN
hls-10800	116	21	)	)	PUNCT
hls-10800	116	22	.	.	PUNCT
hls-10800	117	1	medrxiv	medrxiv	PROPN
hls-10800	117	2	.	.	PUNCT
hls-10800	117	3	2020	2020	NUM
hls-10800	117	4	.	.	PUNCT
hls-10800	118	1	25	25	NUM
hls-10800	118	2	.	.	PUNCT
hls-10800	119	1	sankowski	sankowski	PROPN
hls-10800	119	2	r	r	NOUN
hls-10800	119	3	,	,	PUNCT
hls-10800	119	4	mader	mader	NOUN
hls-10800	119	5	s	s	PROPN
hls-10800	119	6	,	,	PUNCT
hls-10800	119	7	valdés	valdés	PROPN
hls-10800	119	8	-	-	PUNCT
hls-10800	119	9	ferrer	ferrer	PROPN
hls-10800	119	10	si	si	PROPN
hls-10800	119	11	.	.	PROPN
hls-10800	119	12	systemic	systemic	ADJ
hls-10800	119	13	inflammation	inflammation	NOUN
hls-10800	119	14	and	and	CCONJ
hls-10800	119	15	the	the	DET
hls-10800	119	16	brain	brain	NOUN
hls-10800	119	17	:	:	PUNCT
hls-10800	119	18	novel	novel	ADJ
hls-10800	119	19	roles	role	NOUN
hls-10800	119	20	of	of	ADP
hls-10800	119	21	genetic	genetic	ADJ
hls-10800	119	22	,	,	PUNCT
hls-10800	119	23	molecular	molecular	ADJ
hls-10800	119	24	,	,	PUNCT
hls-10800	119	25	and	and	CCONJ
hls-10800	119	26	environmental	environmental	ADJ
hls-10800	119	27	cues	cue	NOUN
hls-10800	119	28	as	as	ADP
hls-10800	119	29	drivers	driver	NOUN
hls-10800	119	30	of	of	ADP
hls-10800	119	31	neurodegeneration	neurodegeneration	NOUN
hls-10800	119	32	.	.	PUNCT
hls-10800	120	1	front	front	ADJ
hls-10800	120	2	cellular	cellular	ADJ
hls-10800	120	3	neurosci	neurosci	NOUN
hls-10800	120	4	2015;9:28	2015;9:28	NOUN
hls-10800	120	5	.	.	PUNCT
hls-10800	121	1	26	26	NUM
hls-10800	121	2	.	.	X
hls-10800	122	1	sasannejad	sasannejad	PROPN
hls-10800	122	2	c	c	PROPN
hls-10800	122	3	,	,	PUNCT
hls-10800	122	4	ely	ely	ADV
hls-10800	122	5	ew	ew	PROPN
hls-10800	122	6	,	,	PUNCT
hls-10800	122	7	lahiri	lahiri	PROPN
hls-10800	122	8	s.	s.	PROPN
hls-10800	122	9	longterm	longterm	PROPN
hls-10800	122	10	cognitive	cognitive	ADJ
hls-10800	122	11	impairment	impairment	NOUN
hls-10800	122	12	after	after	ADP
hls-10800	122	13	acute	acute	ADJ
hls-10800	122	14	respiratory	respiratory	ADJ
hls-10800	122	15	distress	distress	NOUN
hls-10800	122	16	syndrome	syndrome	NOUN
hls-10800	122	17	:	:	PUNCT
hls-10800	122	18	a	a	DET
hls-10800	122	19	review	review	NOUN
hls-10800	122	20	of	of	ADP
hls-10800	122	21	clinical	clinical	ADJ
hls-10800	122	22	impact	impact	NOUN
hls-10800	122	23	and	and	CCONJ
hls-10800	122	24	pathophysiological	pathophysiological	ADJ
hls-10800	122	25	mechanisms	mechanism	NOUN
hls-10800	122	26	.	.	PUNCT
hls-10800	123	1	critical	critical	ADJ
hls-10800	123	2	care	care	NOUN
hls-10800	123	3	2019;23:1	2019;23:1	NUM
hls-10800	123	4	-	-	SYM
hls-10800	123	5	12	12	NUM
hls-10800	123	6	.	.	PUNCT
hls-10800	123	7	27	27	NUM
hls-10800	123	8	.	.	PUNCT
hls-10800	124	1	mcneil	mcneil	PROPN
hls-10800	124	2	jb	jb	PROPN
hls-10800	124	3	,	,	PUNCT
hls-10800	124	4	hughes	hughes	PROPN
hls-10800	124	5	cg	cg	PROPN
hls-10800	124	6	,	,	PUNCT
hls-10800	124	7	girard	girard	PROPN
hls-10800	124	8	t	t	PROPN
hls-10800	124	9	,	,	PUNCT
hls-10800	124	10	et	et	PROPN
hls-10800	124	11	al	al	PROPN
hls-10800	124	12	.	.	PUNCT
hls-10800	124	13	plasma	plasma	NOUN
hls-10800	124	14	biomarkers	biomarker	NOUN
hls-10800	124	15	of	of	ADP
hls-10800	124	16	inflammation	inflammation	NOUN
hls-10800	124	17	,	,	PUNCT
hls-10800	124	18	coagulation	coagulation	NOUN
hls-10800	124	19	,	,	PUNCT
hls-10800	124	20	and	and	CCONJ
hls-10800	124	21	brain	brain	NOUN
hls-10800	124	22	injury	injury	NOUN
hls-10800	124	23	as	as	ADP
hls-10800	124	24	predictors	predictor	NOUN
hls-10800	124	25	of	of	ADP
hls-10800	124	26	delirium	delirium	NOUN
hls-10800	124	27	duration	duration	NOUN
hls-10800	124	28	in	in	ADP
hls-10800	124	29	older	old	ADJ
hls-10800	124	30	hospitalized	hospitalize	VERB
hls-10800	124	31	patients	patient	NOUN
hls-10800	124	32	.	.	PUNCT
hls-10800	125	1	plos	plos	PROPN
hls-10800	125	2	one	one	NUM
hls-10800	125	3	2019;14	2019;14	NUM
hls-10800	125	4	:	:	PUNCT
hls-10800	125	5	e0226412	e0226412	NOUN
hls-10800	125	6	.	.	PUNCT
hls-10800	125	7	28	28	NUM
hls-10800	125	8	.	.	PUNCT
hls-10800	126	1	heneka	heneka	PROPN
hls-10800	126	2	mt	mt	PROPN
hls-10800	126	3	,	,	PUNCT
hls-10800	126	4	carson	carson	PROPN
hls-10800	126	5	mj	mj	PROPN
hls-10800	126	6	,	,	PUNCT
hls-10800	126	7	el	el	PROPN
hls-10800	126	8	khoury	khoury	PROPN
hls-10800	126	9	j	j	PROPN
hls-10800	126	10	,	,	PUNCT
hls-10800	126	11	et	et	PROPN
hls-10800	126	12	al	al	PROPN
hls-10800	126	13	.	.	PROPN
hls-10800	126	14	neuroinflammation	neuroinflammation	PROPN
hls-10800	126	15	in	in	ADP
hls-10800	126	16	alzheimer	alzheimer	PROPN
hls-10800	126	17	’s	’s	PART
hls-10800	126	18	disease	disease	NOUN
hls-10800	126	19	.	.	PUNCT
hls-10800	127	1	lancet	lancet	PROPN
hls-10800	127	2	neurol	neurol	PROPN
hls-10800	127	3	2015;14:388405	2015;14:388405	NUM
hls-10800	127	4	.	.	PROPN
hls-10800	127	5	29	29	NUM
hls-10800	127	6	.	.	PUNCT
hls-10800	128	1	pape	pape	NOUN
hls-10800	128	2	k	k	PROPN
hls-10800	128	3	,	,	PUNCT
hls-10800	128	4	tamouza	tamouza	NOUN
hls-10800	128	5	r	r	NOUN
hls-10800	128	6	,	,	PUNCT
hls-10800	128	7	leboyer	leboyer	NOUN
hls-10800	128	8	m	m	PROPN
hls-10800	128	9	,	,	PUNCT
hls-10800	128	10	zipp	zipp	PROPN
hls-10800	128	11	f.	f.	PROPN
hls-10800	128	12	immunoneuropsychiatry	immunoneuropsychiatry	PROPN
hls-10800	128	13	—	—	PUNCT
hls-10800	128	14	novel	novel	ADJ
hls-10800	128	15	perspectives	perspective	NOUN
hls-10800	128	16	on	on	ADP
hls-10800	128	17	brain	brain	NOUN
hls-10800	128	18	disorders	disorder	NOUN
hls-10800	128	19	.	.	PUNCT
hls-10800	129	1	nature	nature	NOUN
hls-10800	129	2	revi	revi	PROPN
hls-10800	129	3	neurol	neurol	PROPN
hls-10800	129	4	2019;15:317	2019;15:317	NOUN
hls-10800	129	5	-	-	SYM
hls-10800	129	6	28	28	NUM
hls-10800	129	7	.	.	PUNCT
hls-10800	129	8	30	30	NUM
hls-10800	129	9	.	.	PUNCT
hls-10800	130	1	rogers	rogers	PROPN
hls-10800	130	2	jp	jp	PROPN
hls-10800	130	3	,	,	PUNCT
hls-10800	130	4	chesney	chesney	PROPN
hls-10800	130	5	e	e	PROPN
hls-10800	130	6	,	,	PUNCT
hls-10800	130	7	oliver	oliver	PROPN
hls-10800	130	8	d	d	PROPN
hls-10800	130	9	,	,	PUNCT
hls-10800	130	10	et	et	PROPN
hls-10800	130	11	al	al	PROPN
hls-10800	130	12	.	.	PROPN
hls-10800	130	13	psychiatric	psychiatric	ADJ
hls-10800	130	14	and	and	CCONJ
hls-10800	130	15	neuropsychiatric	neuropsychiatric	ADJ
hls-10800	130	16	presentations	presentation	NOUN
hls-10800	130	17	associated	associate	VERB
hls-10800	130	18	with	with	ADP
hls-10800	130	19	severe	severe	ADJ
hls-10800	130	20	coronavirus	coronavirus	NOUN
hls-10800	130	21	infections	infection	NOUN
hls-10800	130	22	:	:	PUNCT
hls-10800	130	23	a	a	DET
hls-10800	130	24	systematic	systematic	ADJ
hls-10800	130	25	review	review	NOUN
hls-10800	130	26	and	and	CCONJ
hls-10800	130	27	meta	meta	NOUN
hls-10800	130	28	-	-	PUNCT
hls-10800	130	29	analysis	analysis	NOUN
hls-10800	130	30	with	with	ADP
hls-10800	130	31	comparison	comparison	NOUN
hls-10800	130	32	to	to	ADP
hls-10800	130	33	the	the	DET
hls-10800	130	34	covid-19	covid-19	PROPN
hls-10800	130	35	pandemic	pandemic	NOUN
hls-10800	130	36	.	.	PUNCT
hls-10800	131	1	lancet	lancet	PROPN
hls-10800	131	2	psychiat	psychiat	PROPN
hls-10800	132	1	2020;7:611	2020;7:611	PROPN
hls-10800	132	2	-	-	SYM
hls-10800	132	3	27	27	NUM
hls-10800	132	4	.	.	PUNCT
hls-10800	133	1	article	article	NOUN
hls-10800	133	2	non	non	ADJ
hls-10800	133	3	-co	-co	PROPN
hls-10800	133	4	mmerc	mmerc	PROPN
hls-10800	133	5	ial	ial	PROPN
hls-10800	133	6	us	us	PROPN
hls-10800	133	7	e	e	NOUN
hls-10800	133	8	o	o	NOUN
hls-10800	133	9	nly	nly	ADV